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ABSTRACT 
 
 
 
Isolation and Effects of Citrus Limonoids on Cytochrome P450 Inhibition, 
 
Apoptotic Induction and Cytotoxicity on Human Cancer Cells.  (December 2005) 
 
Shibu M. Poulose, B.Sc.; M.Sc., University of Agricultural Sciences, 
Bangalore, India 
Co-Chairs of Advisory Committee:   Dr. Bhimanagouda S. Patil 
                                               Dr. Leonard M. Pike 
 
 
This dissertation illustrates an efficient purification method for citrus 
limonoids and flavonoids, while examining their effects on cytochrome P450 
inhibition and apoptotic induction on human neuroblastoma (SH-SY5Y) and 
colonic adenocarcinoma (Caco-2) cells. The first study developed a bulk 
purification method for limonoids, from seeds and molasses of citrus fruits, using 
a combination of chromatographic techniques. This also resulted in an efficient 
purification method for naringin and hesperidin from citrus byproducts.  
 The second study investigated the inhibitory effects of purified limonoids 
and flavonoids on the enzymatic activities of different isoforms of human 
cytochrome P450. O-Dealkylase and hydroxylase activities of CYP1A2, 
CYP1B1, CYP3A4 and CYP19, using specific substrates such as 
ethoxyresorufin (ethoxyresorufin O-dealkylase, EROD), methoxyresorufin 
(methoxyresorufin O-dealkylase, MROD), and dibenzylfluorescein (DBF), were 
 iv  
found to be significantly (P < 0.001) reduced at micromolar levels.  A kinetic 
analysis showed competitive and non-competitive modes of inhibition by 
limonoids, on CYP19 hydroxylase activity. The results corroborate the active role 
of limonoids in the redox cycling mechanisms. 
The third study examined the antioxidant and apoptotic inducing ability of 
limonoid glucosides on human neuroblastoma cells. Four limonoid glucosides, 
LG (17-D glucopyranoside limonin), OG (obacunone 17-D glucopyranoside), 
NAG (nomilinic acid 17-D glucopyranoside), and DNAG (deacetylnomilinic acid 
17-D glucopyranoside), have shown superoxide scavenging at millimolar 
levels.  Micromolar amounts of LG and OG induced rapid necrosis of SH-SY5Y 
cells. Cytotoxicity was correlated (P = 0.046) to a concentration and time-
dependent increase in caspase 3/7 activity. Analyses of DNA content during the 
S phase of the cell cycle indicated reductions of 86.6% for LG and 82.3% for OG 
as compared to untreated. The results validate the antineoplastic distinctiveness 
of limonoid glucosides.  
 In the fourth study, cytotoxic effects of limonoid aglycones and glucosides 
were assessed on human SH-SY5Y neuroblastoma and colon carcinoma 
(CaCo-2) cell lines and compared with the non-cancerous Chinese hamster 
ovary (CHO) cells. Significant (P < 0.001) cytotoxic effects were observed only 
on cancerous cells, over 24 to 36 h. The study revealed a marked increase in 
the DNA content of aneuploidic cells, which results in cell cycle arrest. The 
results confirm that glycosides are the most active apoptotic inducing form.  
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 Background 
 
Citrus is an important fruit crop of tropical and subtropical areas with over 
4000 years history of cultivation (1). The United States contributes nearly one 
sixth of the world citrus production, accounting for nearly 70 million metric tons 
(2). Consumed both as fresh fruits and processed products, the U.S. export 
value of citrus is estimated to be $300 million in 2004-2005 season (3). 
Consumption of citrus has long been known to prevent many human diseases, 
from scurvy to several types of cancers. The health enhancing effects of citrus 
consumption is attributed to the wide assortment of bioactive compounds that  
makeup citrus phytochemicals (4).  The major class of citrus phytochemicals 
includes flavonoids, carotinoids, limonoids, folic acid, pectin, coumarins, vitamin 
C, high quality soluble fiber and mineral potassium (5). Unique among these are 
the limonoids found predominantly in Rutaceae, Meliaceae, Cneoraceae and 
Simaroubaceae families, with citrus being the only edible fruits among these 
families. Limonoids are triterpenoids derived from the precursor 4,4,8-trimethyl-
17-furanylsteroid, with furan and lactone moieties on their ring structures.  
 
______________________ 
This dissertation follows the style and format of the Journal of Nutrition.  
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Limonoids occur both as aglycones, otherwise known as citrus bitter 
principles and as tasteless water-soluble glycosides (6,7). Two enzymes, 
UDPG-limonoid glycosyl transferase and limonoid D-ring lactone hydrolase 
perform the inter-conversion of free to carbohydrate bearing moieties during fruit 
maturation (8). More than thirty-six limonoid aglycones and seventeen limonoid 
glucosides have thus far been isolated from citrus and its hybrids (9). Limonoid 
aglycones contribute to the “delayed bitterness” problem in citrus juices (10). 
The most common aglycones are limonin, nomilin, obacunone and 
deacetylnomilin which are present relatively large concentrations in citrus seeds 
and molasses (6,10).  
A glucose moiety attached to C-17 position of aglycones by a -glycosidic 
linkage makes the respective limonoid glucosides nonbitter and water-soluble. 
Most common among them are limonin 17-D glucopyranoside (LG), 
nomilin17-D glucopyranoside (NG), nomilinic acid 17-D glucopyranoside 
(NAG), obacunone 17-D glucopyranoside (OG), and deacetylnomilinic acid 
17-D glucopyranoside (DNAG). These are found in relatively higher 
concentrations in seeds, and molasses (6-8,11,12). Orange, grapefruit, and 
lemon juices contain an average of 320, 190 and 82 parts per million (ppm) of 
limonoid glucosides (13) and a glass of orange juice contains on average of 66 
mg/L of limonoid glucosides (14). 
Contemporary studies have shown that numerous health benefits are 
derived from limonoid ingestion such as reducing the effects of HIV infections 
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(15,16), serving as antimalarial and anti-inflammatory agents (17), and acting as 
cytotoxic agents against cancers of breast (18), colon (19,20), stomach (21), 
buccal pouch (22-24) and blood (25). Limonoids also have been found to lower 
blood cholesterol (26,27) and induce detoxifying enzymes such as glutathione S-
transferase (GST) (28,29) and cytochrome P450 (30), which are among the 
main targets for antineoplastic strategies. Some, if not all of these properties 
appear to be associated with the ability of limonoids to affect cell growth (31). 
With the plethora of health promoting properties, citrus limonoids appear to be 
potential food supplementations and nutrient additives (11).  
It is necessary to evaluate the biological activity of pure compounds to 
determine the chemopreventive agents in citrus fruits.  However, the low 
concentration of limonoids in fruits and their byproducts makes their extraction 
and purification difficult (12).  Several analytical methods using reversed-phase 
and normal-phase HPLC methods coupled with UV detection have been used to 
separate and detect limonoid aglycones and glucosides in small quantities 
(9,32). Additionally, the methods to isolate, identify and quantify limonoids lack 
specificity and sensitivity and, therefore, have not been very successful in the 
bulk purification of individual compounds required for large scale biological 
activity studies. Many of the carcinogenesis studies involving limonoids were 
performed only with topical applications in animals because of the dearth of 
purified compounds. Recently ion exchange and affinity based synthetic resins 
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have been used for the purification of naturally occurring compounds and could 
be applied for the bulk purification of limonoids from seeds and molasses. 
Despite remarkable treatment advances, cancer remains the leading 
death causing disease among children up to age 14 years in the U.S. and the 
second leading cause of death among adults next to coronary heart disease 
(33). As many as one-third of all cancer deaths in the U.S. could be prevented 
with a healthy, balanced diet emphasizing vegetables, fruits, whole grains and 
beans which have a proven effect in maintaining a healthful weight (33). 
Generation of reactive oxygen species, activation of cytochrome P450 enzymes, 
alteration of cell cycles, and suppression of tumor suppressor genes are among 
the leading causes of the onset of several types of cancers (34,35). 
Consequently, strategies to counter the malignancies of these cancers are vitally 
important.  
 
1.2  Cytochrome P450 isoenzymes  
Cytochrome P450 (CYP) enzymes are hemoprotein monooxygenases 
that catalyze a wide variety of endogenous and xenobiotic compounds (36,37). 
In humans, CYP enzymes have been classified into 18 gene families with over 
50 enzymes in each. Individual isoenzymes are thought to be responsible for the 
metabolism of specific substrates. Some of the most important CYP isoenzymes 
are CYP3A4, CYP1A2, CYPB1 and CYP9, which have a specific role in the 
onset of several types of cancers (38-42). CYP3A4 isoenzyme, the most 
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abundant subfamily, has been implicated in the etiology of prostate cancer (38). 
A higher CYP1A2 level is known to influence risk of lung and colorectal cancers 
(39,40). Recent studies on high levels of E2-4 hydroxylation in estrogen 
responsive tissues have shown CYP1B1 to play an important role in estrogen 
related tumerogenesis (41). CYP19 aromatase catalyzes the conversion of 
androgens to estrogens in the last step of the estrogen biosynthesis pathway. It 
is believed that increased exposure to estrogens is a risk factor for breast cancer 
and, therefore, the human aromatase (CYP19) gene is a plausible candidate for 
low-penetrance breast cancer susceptibility (42). Since CYP enzymes are 
involved in both activation and detoxification in the first pass metabolism, their 
partial inhibition by naturally occurring compounds may represent a novel 
anticarcinogenesis strategy (42). Further, they could reduce the costs on drugs 
by increasing the bioavailability of orally administered drugs (43). Flavonoids of 
grapefruit have been shown to inhibit the activity of certain other human 
cytochrome P450 enzymes (44). Assessing the alkoxyresorufin O-dealkylase 
activity by CYP isoforms is reported to be a good assay system to test the 
inhibitory effects of naturally occurring compounds from citrus and to determine 
the kinetic properties of the inhibition (44). Since bioactive compounds in citrus 
juice have been shown to interact with phase I enzymes, it is imperative to 
determine the inhibitory effect of purified citrus limonoids on CYP isoforms. 
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1.3  Antioxidant activity 
An array of bioactive compounds from fruits and vegetables has been 
shown to act against free radicals that have the potential to damage DNA and 
lead to cancer, coronary heart disease, and other chronic diseases (45-47).  
Activation of GST (28,29) and inhibition of CYP enzymes (30), both enzymes are 
known to work against redox cycling, by citrus limonoids has led to speculation 
that these compounds could be considered as antioxidants. However, no firm 
experimental data are available that support limonoids as having free radical 
quenching abilities. Pyrogallol (1,2,3-benzenetriol) undergoes auto-oxidation in 
the presence of superoxide anion radicals (O2.-) to form purpurogallin. 
Superoxide dismutase (SOD) inhibits this reaction (48) by quenching the 
superoxide radicals which can be measured spectrophotometricaly. This in vitro 
assay serves as an excellent method to test the superoxide quenching ability of 
citrus limonoids. 
 
1.4  Apoptotic induction  
One of the molecular mechanisms underlying the chemoprevention 
properties of limonoids are thought to be through the induction of apoptosis. 
Although there is evidence that suggests limonoids restrain the proliferation of 
some cancerous cell lines, the underlying mechanism is unknown. The human 
SH SY5Y neuroblastoma cell line is an excellent experimental model for the 
study of apoptosis.  Members of the Caspase 3/7 family of proteases have been 
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found to be crucial effectors of the downstream apoptosis signaling (49). So 
deciphering the cytological and biochemical evidence of limonoid induction of 
apoptosis is very revealing.  
Neuroblastomas are embryonal tumors of the peripheral nervous system 
that arise from the neural crest; they account for about 10 percent of childhood 
cancer in U.S. (50). Chemotherapy has not made a significant impact on curing 
these pediatric malignancies (51). A few citrus flavonoids have been shown to 
protect against neuronal injury presumably through caspase pathway (52). 
Human SH-SY5Y neuroblastoma cell lines have been widely used to study 
anticancer drug therapy (53) and could be used to study the biochemical effects 
of citrus limonoids on the induction of apoptosis. Apoptosis, i.e., programmed 
cell death, plays a crucial role in development of several diseases.  
Biochemically, apoptosis is characterized by fragmentation of the genome and 
cleavage and/or degradation of several cellular proteins.  The inhibitory effects 
of citrus limonoids on human cancer cell proliferation in certain types of cancer 
cell lines are postulated to be through the induction of apoptosis.  High 
concentrations of limonoids have been shown to induce apoptosis in breast 
cancer (MCF-7) cells through the use of flow cytometry (31). Members of 
caspase 3/7 family of proteases have been found to be crucial mediators of the 
complex biochemical events associated with apoptosis.  These enzymes have 
substrate specificity for the amino acid sequence Asp-Glu-Val-Asp (DEVD) and 
cleave a number of different proteins including poly (ADP-ribose) polymerase 
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(PARP), DNA dependent protein kinase, and actins.   Z-DEVD-R110 (N-CBC-
Lasp-Lglu-Lval-Lasp-Rhodamine110) is a profluorescent substrate which is 
cleaved at the aspartic acid residue by caspase 3/7, releasing highly fluorescent 
rhodamine-110. This assay system may be used with either cell extracts or 
primary cell suspensions and enables one to identify the regulatory events in the 
apoptotic death process. Overall, studying the effects of limonoids on human 
neuroblastoma cells and their regulatory mechanisms could give fundamental 
evidence for the molecular mechanism of apoptotic induction. Furthermore, 
studying the effects of these compounds at different stages of the cell cycle 
provides critical evidences for the cytostatic effects of these bioactive 
compounds. 
 
1.5  Cytotoxicity on colonic adenocarcinoma  
Colorectal cancer is the second most common cause of deaths related to 
cancer in U.S. Based on the American Cancer Society’s Facts and Figures, 
about 145,000 new cases and about 57,000 deaths due to colorectal cancer will 
occur in 2005 in the U.S. alone (33). Epidemiological studies and animal 
experiments consistently proved the protective effects citrus fruits and their 
bioactive compounds against a wide range of cancers in humans (5). Grapefruit 
juice has been shown to suppress the carcinogen (PhIP) induced colon DNA 
damage (54).  Furthermore, orange juice, which is rich in limonoids and 
flavonoids, significantly inhibited azoxymethane induced colon cancer in male 
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Fisher 344 rats (55).  Similarly, limonin and obacunone inhibited aberrant crypt 
foci (ACF) formation, thereby, inhibiting the pathogenesis of colon cancer (20). 
Considering the advantages of limonoid glucoside over aglycones in water 
solubility and absorption, it is imperative to study the cytotoxic effects of limonoid 
glucosides and other aglycones on human colon cancer cells. It is also important 
to assess the effect of these bioactive compounds on non-cancerous 
mammalian cells, to understand the toxic effects. Hence Chinese hamster ovary 
cells provide an excellent non-cancerous cell model to assess the toxicity of 
these bioactive compounds.  
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CHAPTER II 
 
 
ISOLATION OF LIMONOIDS AND FLAVONOIDS FROM SEEDS AND  
 
MOLASSES OF CITRUS FRUITS 
 
 
2.1 Synopsis 
Limonoids with putative cancer preventive properties were purified from 
seeds and molasses of citrus fruits using a combination of ion exchange and 
size exclusion chromatographies. pH-dependent cold precipitation of a large 
quantity of naringin, prior to the separation of limonoids from flavonoids on a 
styrene/divenylbenzene anionic resin using an increasing salt gradient, was 
found to be critical for higher yields of semi-purified limonoid glucosides. 
Substantial differences were observed with use of different resins on the total 
recovery of limonoid glucosides. High purity limonoid glucosides were obtained 
via reverse phase preparative high performance liquid chromatography and high 
purity limonoid aglycones through direct crystallization. The purity and structures 
of individual compounds were confirmed using LC-MS and NMR. Limonilic acid 
was synthesized from limonin for the structure-bioactivity studies. Hesperidin, a 
major flavonoid of oranges was isolated from orange peels using a pH 
dependent potassium iodide precipitation method. A large scale purification 
method of limonoids and flavonoids from citrus byproducts is presented. 
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2.2 Introduction 
Plant compounds are sources for the development of new drugs and 
model structures for synthetic formulations (56). Citrus fruits contain most of the 
important class of  health promoting bioactive compounds including flavonoids, 
limonoids, carotenoids, vitamin C, coumarins, pectin, folic acid, glucaric acid, 
high quality soluble fiber, and minerals such as potassium (5). Although initial 
speculations on the biological activities of citrus compounds were associated 
with vitamin C, it was later proved that other components impart health 
promoting properties. Limonoids are abundant in citrus fruits, and occur both as 
water insoluble aglycones and soluble glucosides (6,7). The bitter limonoid 
aglycones are converted to nonbitter and tasteless glucosides by UDP-D-
glucose-limonoid glucosyltransferase during fruit maturation (8). Evidence 
suggests that intestinal absorption of limonoids and flavonoids is greatly 
enhanced when ingested as glucosides (57,58).  
Citrus limonoids have numerous health promoting properties in animals 
and human cell culture studies (15-31). Major flavonoids of citrus fruits, naringin, 
narirutin and hesperidin have also been shown to have numerous health 
promoting properties (59-64). Flavonoids are being evaluated as food additives 
by the FDA (65). Because of the growing evidence on the health promoting 
properties, these bioactive compounds could be developed as food nutrient 
additives. Limonilic acid, a modified limonin, has been shown to possess 
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significant antifeedant activity with Colorado potato beetle larvae (66), and thus 
could be used for insect control. 
However, the activity studies of these bioactive compounds rely on the 
availability of pure compounds. Many of the carcinogenesis investigations with 
limonoids were performed either with mixtures or using topical applications in 
animals due to inadequate supplies of pure compounds. Citrus byproducts from 
processing plants are excellent sources for limonoids with more than 500 ppm in 
seeds and molasses (6-8,11,67).  
Procedures to isolate pure limonoids (both aglycones and glucosides) 
have advanced steadily and it is now feasible to prepare and evaluate pure 
materials for anticancer effectiveness. Several methods such as normal-phase 
HPLC (32, 68, 69) reversed-phase HPLC (70,71), NMR (7,72,73), LC/ESI/MS 
(74 -76), have been developed to quantify and/or identify limonoids with different 
degrees of specificity and sensitivity. Adsorption and ion exchange resins have 
greatly facilitated the isolation and purification of many flavonoid and glucoside 
mixtures (11,77). Despite these recent advances, there is still room to improve 
the separation efficiency and increase yields. The current study establishes an 
efficient method for isolation of limonoids, hesperidin, and synthesis of limonilic 
acid from limonin. In addition, a bulk purification method for naringin that 
involves a combination of chromatographic techniques is described.  
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2.3 Materials and methods 
Limonoids and flavonoids source. Seeds of Mexican oranges 
(varieties; Valencia & Navel) were obtained in 100 Kg lots from Monterrey, 
Mexico, dried under shade, and finely powdered in a coffee blender, before 
solvent extraction. Orange and grapefruit molasses were obtained from the 
Texas Citrus Exchange (TCX), a commercial citrus juice plant in Mission, Texas. 
The molasses was stored at 4oC with 0.2% sodium azide added until used.  
Resins and other chemicals. Commercial macroporous, neutral resins, 
such as SP-70, XAD-16 and XAD-2, were purchased from Supelco. Weak anion 
exchangers, i.e., WA-30 and high performance Q-sepharose with exchange and 
binding capacities of 150-200 µeq/mL and of 120 mg/L human serum albumin 
(HSA/mL) respectively, were obtained from Sigma-Aldrich Co.  The strong 
cationic exchanger Dowex-50 was also purchased from Sigma Chemical Co. 
Dowex-50 had an ion exchange capacity of 1.7 meq/mL wet resin, of 100-200 µ 
mesh size, and 50-58% water retention capacity. Small columns (2.5 cm X 10 
cm) were used for evaluation and selection of appropriate resins, e.g., XAD-16, 
XAD-2 and WA30. Bulk purification was accomplished using Dowex-50 (10 cm x 
40 cm column), SP-70 (10 cm x 30 cm column), and Q-sepharose (10 cm x 30 
cm column). The resins were presoaked in methanol, made into a slurry using 
deionized water and added to the column until about two thirds of it was filled. 
The top end of the first column was fitted to a low pressure peristaltic pump and 
the series of columns were interconnected (Fig. 1). The resins were washed 
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until the conductivity of the eluant decreased below 100 µΩ and backwashed 
with three column volumes (CV) of deionized water.  
Selection of resins for glycosidic extracts from seeds. Ethanolic 
extracts of Mexican orange seeds were concentrated by rotary-vacuum 
evaporation. A portion (100 g) of the dried extract was mixed 1:3 with water. The 
pH was adjusted from 4.0 to 6.5 to determine the optimum pH for purification 
and yield with the various resins.  After loading, the columns were washed with 
four column volumes of water and then the compounds were eluted with 80% 
ethanol. The solvent was removed by rotary-evaporation and the product 
weights were determined after freeze-drying.  
Separation of limonoid glucosides from flavonoids. Orange and 
grapefruit molasses (1 kg; 56 and 53o brix of total soluble sugars respectively 
(TSS)) were placed in beakers and the TSS adjusted to 13o Brix with deionized 
water. The slurry was centrifuged at 10,000 gmax for 45 min to remove solids 
and the supernatant was vacuum filtered through Whatman #5 (2.5 µmol/L) filter 
paper. The clarified solution (2400 ml) was loaded onto the Dowex-50 at a flow 
rate 46 mL/min using a peristaltic pump. The Dowex-50 column was connected 
directly to SP-70 adsorbent column.  After loading, the columns were washed 
with 5 CV water. The loading capacity and washing efficiency was determined 
by sampling the discharge from SP-70 and analyzing by TLC (silica gel). The 
compounds adsorbed to SP-70 were eluted with 80% methanol at a flow rate of 
50 mL/min. The eluant was concentrated and the solvent was recovered. The 
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method described by Schoch et al.(11) for efficient separation of limonoids from 
flavonoids was improved by removing naringin in large quantities. After passing 
through Dowex-50 and SP-70 resin columns, 1 Kg of molasses yielded 650 ml 
concentrate (from roto-evoparating the methanol eluant) of pH 2.68. Naringin 
was precipitated from this concentrate by adjusting the pH to 3.5, stirring 
overnight at 4o C. The precipitate was vacuum filtered using Whatman #5 filter 
paper.  The precipitate was then washed with ice cold water to remove all the 
impurities. The precipitated naringin was subsequently dried at 60oC and 
analyzed for purity. The pH of the remaining filtered supernatant was adjusted to 
6.5 and the supernatant loaded onto a Q-sepharose anion exchange column at 
35 mL/min. A linear gradient of NaCl (0-0.6 mol/L) was used to elute the 
compounds and 200 fractions (25 mL each) were collected. The fractions were 
desalted by passing them through a SP-70 column (2.5 cm x 30 cm) and eluted 
with 70% methanol.  Limonoid glucosides were detected by silica gel TLC 
analysis (mobile phase of 5:3:1:1 ethylacetate: ethylmethylketone: formic acid: 
water). Compounds were detected on the TLC plate using Elrich’s reagent (1% 
p-dimethylaminobenzaldehyde in ethanol) in an HCl gas chamber. The 
flavonoids were detected on a UV spectrophotometer at 254 and 280 nm. The 
fractions were freeze-dried and then were weighed.  The purification scheme 
through ion-exchange chromatography and the points where mass balances 
were taken is shown in Figure 2.1. 
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FIGURE 2.1 Sequence of ion-exchange columns in the purification of limonoids 
glucosides and flavonoids from molasses of oranges and grapefruits. A, B, and 
C represents the points where the mass balances were taken. 
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Preparative HPLC separation. Semi-purified limonoid glucoside mixture 
(1 g) was dissolved in 10 ml deionized water and injected to a preparative 
HPLC.  Previously described methods (75,78) were modified to optimize 
resolution of individual peaks by using a mobile phase of 10-25% acetonitrile 
gradient, with 0.003% phosphoric acid. A reverse phase C-18 column (10 cm x 
40 cm, Novapak, Waters Inc.) at 950/ 1150 psi (radial/ back) pressure was used. 
Peaks were monitored using a Waters UV-Photo Diode Array (PDA) detector. 
Individual peaks were collected based on the retention time. Acetonitrile was 
removed using a rotary-evaporator, and the compounds were lyophilized. The 
purity of the compounds and their structures were determined through, HPLC, 
LC-MS and NMR.  
Extraction of limonoid aglycones. The limonoid aglycones were 
extracted by modification of existing methods (79,80). Finely powdered 
grapefruit (varieties; Mexican red and Rio red) and orange seeds (varieties; 
Navel and Valencia) (10 kg/batch) were extracted with 15 L hexane in the 
Soxhlet apparatus for 24 h at 600C. The hexane extract was recovered and 
filtered using Whatman # 5 filterpaper. The hexane extract was partitioned with 
methanol at 1:1 ratio and allowed to settle for 1 hour. The methanol fraction was 
separated and subject to concentrated under reduced pressure (rotary-
evaporation). The resultant concentrate was dissolved in hexane and allowed to 
stand overnight at room temperature. The next day the precipitants were filtered 
using Whatman # 5 filterpaper. The silica gel TLC analysis of the filtered 
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precipitate indicated high concentrations of obacunone and nomilin. This mixture 
was vacuum dried, powdered, and used for open silica column chromatography. 
The hexane defatted seed powder (6.5 kg) was further extracted with acetone 
(15 L) at 60oC for 12 h in a Soxhlet apparatus to remove the aglycones. The 
acetone extract was concentrated under reduced pressure and a rotary-
evaporator. The aglycone mixture dissolved in acetone was spotted on silica gel 
TLC plates (Sigma Aldrich Co.) using ethylacetate:hexane (3:2) mobile phase, 
sprayed with 10% sulfuric acid in methanol, and developed at 110oC for 1 min. 
The Rf values were compared with those of the standards. The compounds 
were further quantified on an analytical HPLC (Waters, Novapack RP-18, 8 mm 
x 40 mm, UV 6000LP detector at 210 nm) using a 10-50% linear gradient of 
water:acetonitrile with 0.003% phosphoric acid. The major aglycone limonin was 
precipitated from the concentrate by dissolving it 1:2 in dichloromethane, and 
allowing it to stand for 1 hour and then vacuum filtering through a Buckner funnel 
using Whatman # 5 filterpaper. Limonin was further purified by washing 
repeatedly with isopropanol and recrystallizing in dichloromethane. Most of the 
limonin was removed by recrystallization (3–4 times). The remaining filtrate was 
rotoevaporated and redissolved in minimum acetone and left at 4oC for 72 h to 
crystallize nomilin. The nomilin crystals were washed with cold isopropanol. The 
leftover filtrate was concentrated and subjected to vacuum liquid 
chromatography to purify minor individual aglycones. 
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Vacuum liquid chromatography (VLC). VLC has been used as an 
alternative technique to conventional chromatographic methods (81) and for the 
purification of bioactive diterpenoids and other compounds (82). This technique 
was used to purify individual aglycones from bulk limonoid aglycone mixtures. 
The filtrate obtained after removal of limonin and nomilin contained concentrated 
amounts of deacetylnomilin, obacunone and traces of limonin and nomilin. The 
filtrate was mixed with TLC grade silica gel (EM Science) with gypsum binder  
(mesh size 2-2.5 µm, pore size 0.75 cm2/g, pore diameter 60oA, Bet surface 
area 500 m2/g, pH 6.8 at 10% aqueous suspension) and subjected to VLC to 
purify individual  compounds. The mixture was finely powdered (until free 
flowing) and added to dry TLC grade silica gel of same properties already in a 
VLC column. A vacuum was applied for about 40 minutes for uniform packing 
and then washed with 100% hexane to check the uniform movement of solvent 
through the column. The mixture was firmly placed on the top of the silica 
packing, covered with a filter paper and vacuum was applied to compact the 
silica packing. A step gradient of 20-80% of ethylacetate:hexane at 5% 
increments (50 mL/step) was used to elute the aglycones from the column and 
individual fractions were analyzed with TLC and pooled based on the individual 
compounds content of the fraction. 
Open column chromatography. Open silica column chromatography 
with a range of mobile phases is widely used for the efficient purification of 
individual bioactive compounds. This is a rapid technique for the separation of 
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minute quantities of compounds (83). Aglycone mixtures devoid of limonin and 
other crystallized aglycones were dissolved in acetone and mixed with equal 
quantities (w/w) of 63-200 mesh size silica gel. The mixture was packed into a 
24/40 column 2.5 cm x 30 cm with 54 g of silica and eluted with 40-70% 
ethylacetate-hexane. The effluent was collected (20 mL fractions) until complete 
elution. The fractions were analyzed by TLC and then pooled depending on their 
content. The unresolved limonin-deacetylnomilin was further separated on 1:1 
mixture of 230-400 mesh silica, eluted with 55% ethylacetate-hexane.  
Synthesis of limonilic acid from limonin. The method for synthesis of 
limonilic acid reported by Emerson (84) was modified. Limonin (8 g) was 
suspended in 250 ml of 0.2 N KOH in methanol contained in a round bottom 
flask equipped with a water cooled condenser. The solution was refluxed for 30 
minutes. After cooling, the methanol was removed under vacuum. The residue 
was dissolved in 100 mL water and 3 g each of Iodine and potassium iodide 
were added. To this mixture 2N NaOH was added until the iodine color was 
changed to a light red/strong orange yellow. After 15 minutes, 5 mg/L of sodium 
sulfite was added and the solution was acidified with 5N HCl. At pH 1 the 
limonilic acid was precipitated. The precipitate was filtered and washed with 
isopropanol and then with hexane to remove Iodine. The purity was confirmed 
via analytical HPLC.  
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Isolation of hesperidin from orange peels. Large quantities of 
hesperidin were isolated via modification of a previously described method (85). 
2.5 Kg of freshly peeled mandarin and orange peels were finely ground with a 
coffee blender, and mixed with 4 L of deionized water. The pH of the slurry was 
raised to 11-12 by addition of calcium hydroxide granules. The elevated pH 
slurry was stirred for 90 minutes and filtered using cheese cloth (3 layers). The 
filtrate was collected and the solids were discarded. The pH of filtrate was 
adjusted to 4.7 with concentrated HCl.  The solution heated to 60oC in a water 
bath for 4 h, stirred for 2 h and held at room temperature overnight. The 
precipitated slurry was vacuum filtered, washed with methanol, and then with 
hexane to remove the impurities.   The filtrate was dried and analyzed using 
analytical HPLC.   
 
2.4 Results 
Selection of resins. The total glucoside yield results, using different 
resins at different pH are summarized in Table 2.1.  The yields were relatively 
higher for SP-70 and XAD-16, compared to other resins tested. Total glucoside 
yield was higher at  pH 4.5, compared to other pH ranges tested (Table 2.1).  
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TABLE 2.1 
Recovery of semi-purified limonoid glucosides from 100 mL of seed 
concentrates using different ion exchange columns at different pH. Values are 
mean (g) ± SD, n= 3. 
 
 pH 
 4.0 4.5 5.0 6.0 6.5 
SP-70 2.69 ± 0.12 3.24 ± 0.16 3.07 ± 0.32 3.14 ± 0.31 2.98 ± 0.13 
XAD-2 1.54 ± 0.17 1.56 ± 0.09 1.42 ± 0.21 1.32 ± 0.24 1.47 ± 0.14 
XAD-16 2.98 ± 0.19 3.14 ± 0.11 2.97 ± 0.17 2.65 ± 0.12 2.64 ± 0.24 
SP70 
&WA-30 
1.38 ± 0.21 1.69 ± 0.17 1.17 ± 0.22 1.32 ± 0.17 1.12 ± 0.16 
 
 
 
TABLE 2.2 
Recovery of limonoid glucosides (g) from 1 Kg of clarified methanolic molasses 
concentrate after the removal of naringin. Values are mean (g) ± SD, n= 4.  
 
 
 
 
                                            Mixture LG OG NAG DNAG 
Orange molasses     
After SP-70 14.21 ±1.28 1.92 ± 0.21 0.91 ± 0.18 0.88 ± 0.27 0.53 ± 0.12 
After Q-sep   9.63 ± 1.01 1.17 ± 0.14 0.79 ± 0.15 0.73 ± 0.11 0.55 ± 0.16 
Final mixture   6.32 ± 0.36 1.28 ± 0.12 0.77 ± 0.21 0.56 ± 0.09 0.43 ± 0.19 
Grapefruit molasses     
After SP-70 12.45 ± 1.23 1.06 ± 0.26 0.98 ± 0.22 0.74 ± 0.32 0.51 ± 0.13 
After Q-sep 7.71 ± 0.82 0.94 ± 0.29 0.82 ± 0.28 0.59 ± 0.19 0.47 ± 0.14 
Final mixture   5.82 ± 0.81 0.97 ± 0.12 0.77 ± 0.19 0.47 ± 0.19 0.39 ± 0.16 
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Separation of limonoids, flavonoids and naringin. The removal of 
naringin was found to be critical for the efficient separation of limonoid 
glucosides from flavonoids. The array of compounds in molasses was 
fractionated on Q-sepharose anion exchanger into limonoids and flavonoids with 
an increasing salt gradient (Fig. 2.2). Methanolic concentrates of 1 Kg grapefruit 
and orange molasses from SP-70 yielded 29.86 ± 3.26 and 22 ± 2.78 g of 
naringin with a higher than 94% purity. Naringin alone comprised of 89% of the 
total flavonoids isolated followed by hesperidin and narirutin. Dowex-50 and SP-
70 resins effectively reduced the impurities (Table 2.2). The HPLC and TLC 
profiles of the freeze-dried Q-sepharose fraction showed limonoid glucosides in 
the initial 33-96 fractions followed by flavonoids in the 80-166 fractions (Fig. 2.2) 
with traces of naringin in all the fractions. Limonoids were separated on the NaCl 
gradient of 0.16 to 0.21 mmol/L while flavonoids separated at 0.23 to 0.48 
mmol/L. An average of 16 g of dried limonoid glucosides and 9.8 g flavonoid 
mixtures were obtained from 1 Kg of clarified citrus molasses concentrate, after 
removing the naringin. The weight of the individual glucosides was calculated 
based the dried isolates from 1 g of limonoid mixture on preparative HPLC 
(Table 2.2).  The peaks collected from the preparative HPLC were confirmed as 
the listed compounds (Fig. 2.3) with more than 90 % purity, by LC-MS and 
NMR. Other limonoid glucosides, e.g., NG and DNG, were isolated in minor 
quantities through preparative HPLC, but the purity of these compounds was 
determined to be less than 75%. 
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FIGURE 2.2 Separation of limonoids from flavonoids using clarified molasses on 
an anion exchange column Q-sepharose, with increasing gradient of sodium 
chloride. Panel A represents the analytical HPLC chromatogram of the clarified 
molasses. Panels B, C represent, chromatograms of limonoid glucosides and 
flavonoids, separated on Q-sepharose.  
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FIGURE 2.3 Structures and analytical HPLC chromatograms with retention time 
for the individual compounds purified by ion-exchange chromatography and 
preparative HPLC. LG = limonin 17-D glucopyranoside, OG = obacunone17-D 
glucopyranoside, NAG = nomilinic acid 17-D glucopyranoside, DNAG = 
deacetylnomilinic acid 17-D glucopyranoside.    
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Purification of limonoid aglycones. For large scale purification of 
limonoid aglycones, soxhlet extraction, direct crystallization, and vacuum liquid 
chromatography, shown to be an efficient method. Crystallization yielded limonin 
with over 95% purity. Though nomilin and deacetylnomilin were directly 
crystallized, the purity of those compounds was observed to be 76% on HPLC; 
therefore, open silica column chromatography and VLC were effective in 
separating large quantities of aglycones (Fig. 2.4). One kilogram of dried 
orange, grapefruit seeds yielded 8.62 and 9.31 g of limonin, 0.62 and 0.47 g 
nomilin, 0.9 and 0.63 g of deacetylnomilin and 0.21 and 0.17 g of obacunone, 
respectively. Considering the abundance of aglycones in seeds, and glucosides 
in molasses, citrus byproducts provide excellent sources for bulk purification 
purposes. 
Limonilic acid, hesperidin and narirutin. Synthesis from 8 g of limonin 
resulted in 6.3 g of pure limonilic acid of 87% purity. The procedure was found to 
be efficient in yield and purity as compared to the previously described method 
(84). Similarly the method reported here for the isolation of hesperidin from 
orange peels was found to be efficient yielding an average 28.7 g for 2.5 Kg 
peels. However, purity of the compound was similar to that the previously 
described. Preparative HPLC separation yielded a 93% pure narirutin product 
(Fig. 2.3), on analytical HPLC.  
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FIGURE 2.4 Structures and analytical HPLC chromatograms with retention time 
for the individual limonoid aglycones. Resolved on a mobile phase of 10-50% 
acetonitrile in water with 0.003% phosphoric acid, using a reverse phase C-18 
column at 1 mL/min flow rate.  
 
 
2.5 Discussion 
Adsorption and ion-exchange resin load capacity is a key parameter for 
limonoid purification. When compared to the other resins, SP-70 had an 
increased yield at pH 4.5. The ion-exchange mechanism involved in this 
purification process is well characterized for other compounds (86). The 
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adsorption-desorption properties of limonoids on adsorbent resins like SP-70 
can be summarized in the following steps: (i) selective movement of limonoids in 
solution to the boundary of resin particles, (ii) attachment of limonoid glucosides 
to the surface of the resin, (iii) diffusion to the intra-particle active sites from the 
surface, (iv) attachment and desorption depending upon the molecular size, 
charge of the molecule and polarity of the mobile phase. The differences in 
yields at various pH’s could be due to conformational changes that glucosides 
undergo as a function of pH.  
The ion-exchange process depends on the ionic strength of the mobile 
phase and desorption increases with increase in the conductivity (87). A lower 
degree of cross-linking in a cationic exchanger like Dowex-50 eliminates 
polyelectrolytes and emulsifier anions (88) which aid in the elimination of colored 
impurities from molasses. The rate of the adsorption/desorption processes on an 
anionic resin is determined by the number of charged groups on the molecule. 
Structural properties of limonoid glucosides exhibit a negatively charged open D-
ring with a glucose moiety attached to it. In the case of acidic glucosides like 
NAG and DNAG, both the A and D rings are open. From the fractionation pattern 
(Fig. 2.2) it is evident that the negative charges on limonoid glucosides and 
flavonoids molecules alter the conductivity and separation on anionic resins is 
affected by an increasing salt gradient. The increase in yield over the previously 
described method (11) can be ascribed to the separation of naringin at the initial 
stages of separation. Although more than 17 limonoid glucosides have been 
 29  
identified from citrus (6), only the four most abundant glucosides have been 
characterized (Table 2.2) for use in further biological activity studies.  
 Extraction of aglycones using a Soxhlet apparatus remains to be proven 
an efficient method of extraction. Direct crystallization was successful in 
providing a large quantity of high purity limonin. The availability of seeds and 
molasses from the juice processing plants makes for an inexpensive source of 
raw materials. Large scale purification of desired products from seeds and 
molasses via the Soxhlet extraction, direct crystallization, VLC, and silica column 
chromatography proves to be inexpensive and efficient. These methods are 
applicable for industrial purification. Similarly, the synthesis of limonilic acid, 
precipitation of hesperidin, and separation of narirutin are also suitable for the 
bulk purification to meet commercial needs. 
In conclusion, large amounts of pure limonoids and flavonoids are needed 
to elucidate their cancer preventive properties. The bulk purification methods 
reported in this chapter prove to be economical and efficient. The isolation and 
activity studies with pure compounds could provide critical information regarding 
the structure-activity relationship, molecular mechanisms, and biochemical 
interaction, thereby could aid as lead structures for new drug development.   
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CHAPTER III 
 
 
 
INHIBITORY EFFECTS OF CITRUS LIMONOIDS AND FLAVONOIDS ON  
 
HUMAN CYTOCHROME P450 ISOENZYMES 
 
 
3.1 Synopsis 
The effects of limonoids and flavonoids on O-dealkylase and hydroxylase 
activities of human cytochrome P450 (CYPs) isozymes such as CYP1A2, 
CYP1B1, CYP3A4 and CYP19 were measured using the substrates 
ethoxyresorufin (ethoxyresorufin O-dealkylase, EROD), methoxyresorufin 
(methoxyresorufin O-dealkylase, MROD), and dibenzylflurescein (DBF). The 
kinetic studies resulted in variable inhibition of CYPs in concentration dependent 
assays. Significant (P < 0.001) reductions in enzyme activities were observed, 
with purified compounds above 2 µmol/L. Kinetic analysis indicated that limonin 
glucoside inhibited CYP19 hydroxylase competitively, while nomilinic acid 
glucoside in a non-competitive mode. IC50 values were less for glucosides than 
for the aglycones. The results support prior suggestions for an active role of 
these compounds in the redox cycling. The variation in efficacy by different 
limonoids can be ascribed to the structural variation of the molecules. Limonoid 
inhibition of key CYPs involved in carcinogenesis supports growing evidences 
that citrus bioactive compounds can act as anticancer agents.    
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3.2 Introduction 
Exposure to environmental chemicals is considered as a major risk factor 
for several types of cancers. These exposures can result in the generation of 
reactive oxygen (e.g., singlet oxygen, superoxide) and nitrogen (e.g., 
peroxynitrite, nitrogen dioxide) species (89) which have been implicated as 
causative agents for many diseases including inflammatory and degenerative 
diseases, arthritis, retinitis pigmentosis, coronary artery diseases, and many 
types of cancers (89,90). In humans, many of the chemicals are pre-carcinogens 
and are activated to carcinogenic and mutagenic substances by microsomal 
enzymes (89,91). The human microsomal enzyme system consists of scores of 
cytochrome P450 isoenzymes. In vitro studies with certain phytochemicals 
revealed a reduction in activities involved with generation of carcinogens through 
partial inhibition of these enzymes (44,92,93).   
Cytochrome P450 enzymes are electron-transporting proteins that 
contain a heme-prosthetic group in which the iron alternates between reduced 
ferrous (Fe2+) and oxidized (ferric, Fe3+) state (Fig. 3.1) (94). The CYPs are 
known to be involved in the metabolic activation and detoxification of 
environmental carcinogens, orally administered drugs, steroids, bile acids, fatty 
acids, eicosanoids, and fat soluble vitamins (91,95). Activation involves the 
formation of reactive oxygen species (ROS) that may interact with DNA of target 
cells (91,96). In humans, CYP enzymes have been classified into 18 gene 
families with over 50 enzymes in each (97) and are mostly found on the 
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endoplasmic reticulum. Individual isoenzymes are thought to be responsible for 
the metabolism of specific substrates. Some of the most important cytochrome 
P450 isoenzymes are CYP3A4, CYP1A2, CYP1B1, and CYP19, which have 
specific roles in the onset of several types of cancers (38-41,91,96). Thus, 
inhibition of CYPs by naturally occurring compounds may represent a novel 
approach in the anticarcinogenesis strategy (42,95).  
Citrus products contain several vitamins, minerals, and an array of 
bioactive compounds. The bioactive compounds in citrus fruits have been shown 
to possess numerous cancer preventive properties (2,5).  Much of current 
research is being focused on limonoids and flavonoids. Limonoids are unique to 
citrus. Contemporary studies have shown that limonoids have numerous health 
benefits such as countering the effects of HIV infections, serving as 
antimalarials, anti-inflammatory agents, and as cytotoxic-cytostatic agents 
against several types of cancers (15-31). Limonoids are shown to be non-toxic 
to the normal cells (31). The effect of limonoids and flavonoids in inducing 
glutathione S-transferase (GST), a major phase II detoxifying enzyme (5,24,28) 
and specific role on certain CYP activity (30) lead us to postulate that one of the 
antineoplastic properties of these compounds could be through inhibition of 
cytochrome P450 enzymes, thereby reducing carcinogenesis. Here we report 
the effects of citrus limonoid aglycones, glucosides, and flavonoids on the 
activity of human cytochrome p450 isoenzymes (CYP1A2, CYP1B1, CYP3A4, 
CYP19) using alkoxyresorufins and dibenzylfluorescein (DBF) as substrates. 
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FIGURE 3.1 Oxidation-reduction catalytic mechanisms of CYPs  
 
 
3.3 Materials and methods 
Limonoids and flavonoids. The compounds were isolated from seeds 
and molasses of citrus fruits as described in the previous chapter. The pure 
compounds and mixtures were used to elucidate the inhibitory effects on CYP 
isoforms. The glucoside mixture was comprised of about 32% limonin glucoside, 
34% obacunone glucoside, 12% nomilinic acid glucoside, 9% nomilin glucoside, 
8% deacetylnomilinic acid glucoside, and 4% deacetylnomilin glucoside. The 
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aglycone mixture used for the CYP activity assay consisted of 49% limonin, 17% 
deacetylnomilin, 14% nomilin, 8% obacunone, and 12% other aglycones in 
minor concentrations, based on the HPLC profiles. The stock solutions (1 mol/L) 
were prepared in DMSO for individual limonoid aglycones and in water for pure 
limonoid glucosides. The stock solutions for the mixtures were in ppm. The 
DMSO concentration was maintained below 0.1% in the CYP reaction mixtures.  
CYP isoforms and substrates. Alkoxyresorufins (e.g., methoxyresorufin, 
and ethoxyresorufin) were synthesized as described by Mayer et al.(98). DBF 
and ketoconazole were purchased from Sigma-Aldrich Co. (St. Louis, MO, 
USA). Human liver expressed CYP isoenzymes CYP1A2, CYP1B1, CYP3A4, 
CYP19 and NADPH oxidoreductase were purchased from BD Gentest Inc. 
(Woburn, MA, USA). Activity of all these isoforms were expressed from human 
CYP1A2 cDNA using baculovirus infected (BTI-TN-5B1-4) expression system.  
Methoxy-, ethoxy-O-dealkylase and hydroxylase activities of CYPs. 
Methoxyresorufin and ethoxyresorufin were used as substrates for CYP1A2 and 
CYP1B1. DBF was the substrate for CYP3A4 and CYP19. Ketoconazole (0.25 
µmol/L) was used as positive control.  The MROD and EROD activities of 
CYP1B1 and CYP1A2 were determined fluorometrically as described by Burke 
et al. (99). The substrates (1 mol/L) were prepared in DMSO. The reaction 
mixture (500 µL) contained 0.5 to 10 µmol/L citrus limonoids, 0.2 to 40 µmol/L 
substrates, 2-10 pmol/L CYP. The volume was made up using proportional 
volumes of 1.3 mmol/L NADP+, 3.3 mmol/L glucose 6-phosphate. 0.4 units/mL 
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glucose 6-phosphate dehydrogenase, 3.3 mmol/L MgCl2 in 0.1M phosphate 
buffer, pH 7.4.  Ice cold NADPH oxidoreductase was added just before the start 
of the reaction.  A Synergy HT fluorescence plate reader (Bio-Tek Instruments, 
Inc., Winooski, VA), equipped with 530 ± 15 nm excitation and 590 ± 15 nm 
emission  filters was used to determine the kinetic and endpoint fluorescence of 
resorufin. Hydroxylation of DBF was measured by following the formation of 
fluorescein (485 ± 15 nm excitation, 538 ± 15 nm emission). The DBF reactions 
were terminated at 30 minutes duration with 2 mol/L NaOH, using the same 
plate reader. Reaction products were quantified using resorufin and fluorescein 
standards. Inhibitor concentrations that produce 50% inhibition (IC50) were 
calculated as previously described (100).  
Statistical analysis. All the experiments were done in triplicate. The data 
were analyzed by one way ANOVA using SPSS statistical analysis software 
(Version 11.0). Comparisons were made within and between groups using 
Fisher’s least significant difference test and Dunnet’s paired comparisons.   
 
3.4 Results 
All of the limonoids significantly (P < 0.001) inhibited EROD 
(ethoxyresorufin O-dealkylase) activity of CYP1B1 (Fig. 3.2A,B). However, there 
were no significant differences between 0.5 and 2.0 µmol/L of LG (P = 0.350), 
limonin (P = 0.120), and 2 to 5 µmol/L obacunone (P = 0.011) and nomilin (P = 
0.02). Limonoid glucosides were better inhibitors than aglycones (Fig. 3.2A,B).  
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FIGURE 3.2 Ethoxyresorufin and methoxyresorufin O-dealkylase (EROD, 
MROD) activities of CYP1B1 treated with limonoid glucosides  (panels A,C) and 
limonoid aglycones (panels B,D). Values are mean ± SEM, n = 3. C (control), 
Lim (limonin), Obc (obacunone), Nom (nomilin) and Dan (deacetylnomilin). 
 
The acidic limonoid glucoside, NAG, had the highest inhibitory effect. All 
of the limonoid glucosides significantly (P < 0.001) inhibited MROD activity of 
CYP1B1 (Fig. 3.2C,D). Fisher’s least square differences on mean metabolite 
production (MROD) by CYP1A2 treated with different levels of limonoids 
indicated that all the compounds were effective (P < 0.005) inhibitors when 
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compared to untreated human CYP (Fig. 3.3A,B). Likewise, all of the flavonoids 
significantly (P < 0.001) inhibited CYP1A2 MROD activity.  
Human aromatase, CYP19, was inhibited by limonoid glucosides in two 
different modes as shown in Figure 3.4. Inhibitory effects of LG were reversible 
with increasing concentrations of DBF (Fig. 3.4A), whereas NAG, the acidic 
glucoside exhibited non-competitive inhibition (Fig. 3.4B), with the same enzyme.  
The limonoid glucosides and aglycones were effective inhibitors of CYP3A4 DBF 
hydroxylation (Fig. 3.5). NAG and nomilin were apparently the best inhibitors of 
CYP3A4 DBF hydroxylation (Fig. 3.5); this is similar to what was observed for 
CYP1B1 EROD activity.  
The IC50‘s of the limonoids for the various CYPs varied considerably 
(Table 3.1). Overall the IC50 values were lower for limonoid glucosides, than 
those calculated for the aglycones. The nomilinic acid glucosides (NAG) were 
found to be the most effective limonoid inhibitors for most of the isoforms tested. 
The glucoside mixture used in this study was comprised of about 32% limonin 
glucoside, 34% obacunone glucoside, 12% nomilinic acid glucoside, 9% nomilin 
glucoside, 8% deacetylnomilinic acid glucoside, and 4% deacetylnomilin 
glucoside. The mixtures could not be compared against the pure compounds, 
instead used as a representative of the total glycosides in a juice or fruit. 
Similarly aglycone mixture used for the CYP activity assay consisted of 49% 
limonin, 17% deacetylnomilin, 14% nomilin, 8% obacunone, and other aglycones 
in minor concentration. 
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FIGURE 3.3. Effects of limonoid glucosides (A) and limonoid aglycones (B) on 
MROD activity of CYP1A2. Panels C,D indicate the effects of flavonoids on 
EROD and MROD activities of CYP1B1 and  CYP1A2 respectively.  Values are 
mean + SEM, n = 3. 
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FIGURE 3.4 Lineweaver-Burk plot for the mode of inhibition of NAG and LG on 
CYP19 hydroxylase activity. Nomilinic acid glucoside (NAG) inhibited CYP19 in 
anon competitive mode (A), while limonin glucoside (LG) inhibited competitively 
(B). Values are mean ± SEM, n = 3.   
FIGURE 3.5 Effect of limonoid glycosides and aglycones on the hydroxylation of 
DBF, a measure of CYP3A4 activity. Values are in mean ± SEM, n = 4. 
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TABLE 3.1 
IC-50 values for citrus limonoids on different CYPs.  Expressed as µmol/L. or as 
ppm (*).  
 
 
 
3.5 Discussion 
The variation in IC50 values for different limonoids can be ascribed to the 
affinity of substrates/limonoids towards various enzymes in the formation of 
enzyme-substrate/inhibitor complex. The better solubility and uptake of 
glycosides over aglycones cannot be considered a critical factor as the 
aglycones were dissolved in DMSO which may have influenced their solubility 
and uptake. The multiple open rings and two reactive carboxyl groups on the 
acidic limonoid glycoside, NAG could be a factor for better inhibitor efficacy. 
These results confirm a definite role of the acidic glucoside in the redox cycling 
 EROD1B1 MROD1B1 MROD1A2 CYP3A4 CYP19 
LG 22.16 9.01 13.94 13.34 7.06 
OG 13.68 10.09 17.16 23.56 13.71 
NAG 8.25 4.36 9.41 8.77 9.43 
DNAG 10.03 18.76 13.74 18.89 27.79 
Glycoside Mix* 3.12 7.12 8.55 5.06 6.34 
Limonin 31.97 26.5 54.86 36.63 29.92 
Obacunone 11.36 21.36 13.24 20.9 27.97 
Nomilin 20.62 24.06 31.01 10.43 16.43 
Deacetylnomilin 10.74 17.06 28.24 63.21 51.24 
Aglycone Mix* 6.77 13.76 12.08 8.7 14.64 
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mechanism which involves many enzymes including CYPs. However, compared 
to the IC50’s of many citrus flavonoids and furocoumarins (37,42,101), limonoids 
are poorer inhibitors for the isoenzymes tested. This study confirms the 
previously reported non-significant effects of limonin and nomilin, on various 
isoforms of CYPs in liver and intestine of rats at lower doses (30).     
In humans, cytochrome P450 monooxygenases catalyze a wide variety of 
both endogenous and xenobiotic compounds (37). Recent studies on high levels 
of E2-4 hydroxylation in estrogen responsive tissues have shown CYP1B1 to 
play an important role in estrogen related tumerogenesis (42). Limonoid 
glucosides are better inhibitors of CYP1B1 than the limonoid aglycones. 
Moreover, all of the compounds partially inhibited these isoenzymes at 
micromolar levels. Epidemiological studies have shown increased risk of colon 
cancer in individuals with high CYP1A2 activity based on caffeine metabolism 
(102).  Higher CYP1A2 activity has also been shown to influence the risk of lung 
cancer (39).  Tanaka et al. (19,20) had earlier reported that obacunone and 
limonin reduced the azoxymethane induced colon carcinogenesis in rats. This 
study confirms the effects of other limonoids as inhibitors of CYP1A2 which has 
a direct role in the etiology of colon cancer.  This also corroborates earlier claims 
that bioactive compounds in orange and grapefruit juice can reduce the food 
carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo pyridine) and AOM 
(azoxymethane) induced colon cancer in rats (54,55). CYP19, the steroid 
aromatase, catalyzes the conversion of androgens to estrogens. An increased 
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exposure to estrogens is considered a risk factor for breast cancer. Therefore, 
CYP19 is a plausible candidate for low-penetrance breast cancer (41,95). The 
decreased expression of CYP19 is propitious for the reduction of estrogen 
dependent tumors (103). LG and NAG inhibited CYP19 aromatase activity in 
competitive and non-competitive modes, respectively. This supports earlier 
claims by Miller et al. (13), So et al. (18), and Tian et al. (31), that some citrus 
limonoids and other bioactive compounds in orange and grapefruit juice reduce 
mammary tumerogenesis in rats as well as in the human breast cancer cells. 
CYP3A4, the most abundant subfamily of CYPs, has been implicated in the 
etiology of prostate cancer (38). Therefore, partial inhibition of CYP3A4 by citrus 
bioactive compounds, could aid in the reduction of prostate cancer. Increased 
plasma concentrations of orally administered drugs can be caused by the 
inhibition of CYP3A4 enzymes which play a pivotal role in the oxidative 
biotransformation of many drugs (37,93,95,101). Consequently, partial inhibition 
of these enzymes would prolong the bioavailability of administered drugs by 
lowering their turnover; inhibition could reduce the medical costs by extending 
drug half-lives (43,95). Partial inhibition of CYP3A4 by limonoids, also could 
contribute to the increased bioavailability of orally administered drugs when co-
administered with grapefruit juice. But the IC50 values observed for limonoids 
are much higher compared to other compounds such as furocoumarins and 
flavonoids, present in the grapefruit juice. Further research on dose response 
relationships of drugs interacting with citrus bioactive compounds could reduce 
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the threat of potential toxicity problems resulting from elevated drug levels. In 
mammalian systems, the induction of CYPs is known to be mediated through the 
expression of specific receptors like aryl hydrocarbon receptor (AhR) (93). AhR 
receptors have been primarily implicated in the over-expression of CYP1A2, 
CYP1B1 and other CYP1 family of enzymes (93). Some flavonoids have been 
shown to bind the AhR receptors without activating the transcription factor, 
thereby acting as antagonists of CYPs (93).  Thus, we can speculate that the 
limonoids bind to some of this specific receptor, triggering the inhibitory effect. 
In conclusion, citrus limonoids and flavonoids have been shown to effect 
redox-cycling enzymes in a dose dependent and dose independent manner. 
Limonoids partially inhibited the dealkylase and hydroxylase activity of 
cytochrome P450 isoforms at the levels tested. Inhibition of CYP enzymes 
represents a unique mechanism in the anticarcinogenesis strategy, part of which 
includes reducing the generation of reactive oxygen species. The presence of 
citrus bioactive compounds increased the bioavailability of orally administered 
drugs, by inhibiting CYP3A4 and could reduce medical costs. Dose responses 
and interactions need to be determined with prescribed drugs.  
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CHAPTER IV 
 
 
LIMONOID GLUCOSIDES INDUCE APOPTOSIS IN SH-SY5Y HUMAN 
 
NEUROBLASTOMA CELLS AND HAVE ANTIOXIDANT PROPERTIES* 
 
 
4.1 Synopsis 
 
 Limonoid glucosides have been postulated to have free radical-
scavenging and apoptosis-inducing properties against certain types of cancers.  
In this study four highly purified limonoid glucosides. i.e, LG, OG, NAG, and 
DNAG, were tested for superoxide radical (O2-) quenching activity and 
cytotoxicity against cultured undifferentiated human SH-SY5Y neuroblastoma 
cells.  Four limonoid glucosides have shown superoxide scavenging abilities and 
NAG, in particular, emulated the quenching effect to an equivalent concentration 
of vitamin C.  Micromolar amounts of LG and OG induced rapid necrosis of 
cultured SH-SY5Y cells.  Viability studies showed significant reduction in live 
cells within 24 h of treatment with LG and OG. Cytotoxicity was correlated (P = 
0.046) to a concentration and time-dependent increase in caspase 3/7 activity.  
DNA content at the S phase of the cell cycle indicated a significant reduction 
with limonoid treatment. The results strongly suggest the antineoplastic 
properties of limonoid glucosides. 
 
* Reprinted with permission from “Citrus Limonoids Induce Apoptosis in Human 
Neuroblastoma Cells and Have Radical Scavenging Activity” by Poulose, S. 
M., Harris, E. D. & Patil, B. S., 2005, Journal of Nutrition. 135: 870-877. 
Copyright 2005 by Journal of Nutrition. 
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4.2 Introduction 
 Limonoid glucosides are a class of furan-containing triterpenes that are 
highly water soluble, non-bitter in taste and that have been shown to be effective 
against several types of cancers (4,5). Thus far, more than 19 limonoid 
glucosides have been isolated and characterized from citrus and their related 
species. Two enzymes, UDPG-limonoid glycosyl transferase and limonoid D-ring 
lactone hydrolase perform the inter-conversion of bitter limonoid aglycones to 
carbohydrate-bearing limonoid glucosides (8). The transferase gene has been 
isolated and cloned (104). Glucoside content in citrus juice is much higher than 
that of aglycones (13) and the glucosides are absorbed better due to higher 
water solubility (11). However, bioavailability studies have shown that the once 
absorbed, glucosides lose the glucose moiety and appear as aglycones in the 
blood serum (105).  
 Recent studies have shown numerous health benefits from limonoid 
ingestion, including the prevention of several types of cancer (15-31).  Some, if 
not all of these cancer preventive properties appear to be associated with 
limonoid glucosides effects on cell growth (31). This study focuses on the 
mechanism for blocking cancer cell growth.   
Bioactive compounds are known to play pivotal roles in detoxifying 
reactive oxygen species (ROS) and limiting their severity or preventing the 
occurrence of many types of cancers.  While there is one report on the 
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antioxidant capacity of a few limonoids (106), there is no concrete evidence on 
the type of reactive species involved in supporting such a role.  Studies on 
carcinogen detoxification properties of limonoids, in mammalian system, have 
focused on the induction of glutathione S-transferase activity (12,16,17). We 
have shown the inhibitory effects of limonoids on several cytochrome P450 
isoforms. GSTs and CYPs are known to work against redox cycling and assist in 
detoxification of many types of compounds.  Here we provide biochemical 
evidence that specific limonoid glucosides have the capacity to quench 
superoxide radicals and intercede with the production of ROS.  
Neuroblastoma, a common extra-cranial solid tumor in children, accounts 
for 10% of all cancers and up to 50% of malignancies among children (50,107). 
In this study reports a second facet of limonoid glucosides in inducing apoptosis, 
as measured by cytotoxic action against the neuroblastoma cell line SH-SY5Y.  
A surprising finding was an inequality in quenching and apoptotic-inducing 
properties of individual limonoid glucosides, suggesting that chemopreventative 
properties rely on the arrangement of specific functional groups within the 
structure of the molecule.    
 
4.3 Material and methods 
Limonoids and chemicals.  Four limonoid glucosides (Fig 4.1), purified 
via preparative HPLC as described in the previous chapters were used for the 
activity studies described below.  Pyrogallol, ascorbic acid, camptothecin, MTT 
 47  
(bromure of 3(4,5-dimethylthiaszol-2-yl)-2,5-diphenyltetrazolium), propidium 
iodide were purchased from Sigma Aldrich, Inc.  Standard rhodamine, caspase 
specific substrate Z-DEVD-R110, and caspase inhibitor Z-DEVD-CHO were 
obtained from Molecular Probes.  
 
FIGURE 4.1 Purified citrus limonoid glucosides used for the study. 
 
Cell cultures. SH-SY5Y human neuroblastoma cells (CRL-2266) were 
purchased from the American Type Culture Collection (Bethesda, MD) and 
cultured in 10% (v/v) fetal bovine serum in a 1:1 mixture of Eagle’s minimum 
essential medium with non-essential amino acids, 0.001% antimycotic-antibiotic 
and Ham’s F12 medium (108).  Cells were grown on 25 cm2 falcon culture flasks 
at 37oC under 5% CO2.  When the cells reached 70-80% confluence they were 
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detached from the flasks with Pucks EDTA solution and quantified in a 
hemocytometer.  Approximately 15 x 103 cells were subcultured into 12, 24- and 
96-well plates for experiments.   
Superoxide radical quenching. Assays for O2- radical quenching 
followed the procedure described by Marklund and Marklund (48) with the 
exception that the assays were performed at pH 7.6, which is closer to biological 
pH, and pyrogallol was present at a concentration of 0.2 mmol/L.  Stock 
solutions of 1 mmol/L pyrogallol were prepared in 0.5 M HCl and diluted to the 
desired concentration and pH with 0.2 mol/L Tris-HCl.  These adjustments 
allowed for a more sensitive measurement of limonoid quenching.  Individual 
limonoid glucosides were added to a final concentration of 0.1-10 mmol/L and 
continuous absorbance readings were taken over 10 min in a Hitachi U2001 
recording UV-visible spectrophotometer at wavelengths corresponding to 
purpurogallin (325 nm), purpurogalloquinone (600 nm) and the peroxidation 
species of purpurogalloquinone (440 nm).  Decomposition rates were 
determined by the slope of the absorbance curve.  Quenching was assessed by 
measuring decomposition rate against samples treated with 40 U of superoxide 
dismutase (Sigma-Aldrich).    
Measurements of cell viability. SH-SY5Y cells in triplicate were 
incubated in culture medium supplemented with limonoid glucosides (1-100 
µmol/L final concentration) and cell viability was monitored at 12 h intervals over 
the next 72 h.  Viability determinations were based on trypan blue exclusion as 
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measured in a hemocytometer and the MTT reagent (3[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium) as described (109).   
Assay of caspase 3/7 activity. Upon reaching confluence, SH-SY5Y 
cells were harvested and co-cultured into 24-well culture plates.  After 24 h 
individual cultures in triplicate were treated with limonoid glucosides.    At 12, 24, 
36 and 48 h after treatment, the cells were harvested, washed three times with 
PBS buffer and collected by centrifugation (5000 x g, 2 min, 4oC) and the cell 
pellet was taken up in 200 µL of lysis buffer (0.2 mol/L Tris, pH 7.5, 2 mol/L 
NaCl, 0.02 mol/L EDTA, 0.02% (v/v) Triton-X100).  Aliquots were analyzed for 
protein using the BCA reagent (Pierce) and a lysate volume equivalent to 50 µg 
of protein was brought to 100 µL with buffer in a 96-well flat bottom black 
microtiter plate. An equal volume of caspase substrate (Z-DEVD-R110) was 
added with mixing and the plate was covered with aluminum foil and set aside at 
37oC for 30 min. Fluorescence measurements were performed over a 2 h period 
in a Perkin-Elmer LS50B luminescence spectrometer, using 499 nm excitation 
and 521 nm emission wavelengths.  Controls with no limonoid glucosides or with 
camptothecin, a strong apoptosis inducer, were run concurrently.  Caspase 
activity was expressed as pmol/L rhodamine/min/µg protein.  Other controls 
consisted of limonoid glucosides or camptothecin combined with a known 
caspase 3/7 inhibitor  AC-DEVD-CHO. 
Flow cytometry analysis. The cells were treated with limonoid 
glucosides or camptothecin for 12, 24, 36, and 48 h and harvested as before. 
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Between 106 to 107 cells in PBS were centrifuged (200 x g, 6 min, 25oC), and the 
cell pellet was taken up in 50 mL of PBS, 450 mL of 70% ethanol, and stored at -
20oC until used.  Cells were separated from the ethanol by centrifugation at 200 
x g for 5 min, decanting the ethanol, and suspended in 1 mL of 0.1% (v/v) Triton 
X-100 in PBS, to which was added 200 µg of DNase-free RNase A and 20 µL of 
propidium iodide.  After 15 min incubation at 37oC to destroy RNA, the 
suspension was filtered through nylon and collected in tubes that fit a Beckton 
Dickenson FACS Caliber flow cytometer.  DNA fluorescence readings were 
taken with an excitation blue light set and 488 nm and a detector emission of red 
fluorescence through a 585 nm filter.  Pulse width area signals were used to 
discriminate between G2 cells and cell doublets.  The data were analyzed using 
ModFitLT software version 3.1 (PMac).  
Statistical analysis. Experimental results represent triplicate 
experiments for each treatment group and are expressed as means ± standard 
error.  A two-way ANOVA was used with a P-value of less than 0.05 (Fisher’s 
least significant difference test) considered to indicate significance and Dunnet’s 
paired comparison.  Analyses were done with SPSS statistical analysis software, 
(Version 11.0).  The coefficient of variation in the DNA analysis was less than 
6%.  Reduced  chi square goodness of fit was assumed to be 0.8 to 3.0.  IC50 
values for the inhibition concentration for individual compounds were calculated 
after Stahle et al. (100), using a linear regression equation.  
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4.4 Results 
Superoxide quenching activity. The potential for the purified limonoid 
glucosides to quench free radicals was ascertained using pyrogallol in slightly 
alkaline (pH 7.6) solutions.  Quenching superoxide anion (O2-) effectively stops 
the spontaneous decomposition of the pyrogallol, which can be measured 
spectrophotometrically at wavelengths corresponding to the oxidized products of 
pyrogallol.  Assays were run with limonoid glucoside concentrations varying 
between 0.1 and 10 mmol/L.  Typically, a short lag phase at the start was used 
to measure quenching activity (Fig. 4.2).  As shown in Figure 4.2A, at 5 mmol/L, 
clearly discernible differences in the quenching efficacies of the different 
limonoid glucosides were observed.  NAG was superior to LG, OG, and DNAG 
over the 5 min assay time (Fig. 4.2A).  At 5 mmol/L NAG had nearly the same 
quenching efficacy as L-ascorbic acid and superoxide dismutase.  Testing NAG 
alone showed that strong and sustained inhibition, which was not seen until the 
concentration was above 1 mmol/L (Fig. 4.2B).  Neither change in the pH nor 
pyrogallol concentration affected the profiles for the different limonoid 
glucosides.    The rate of inhibition of purpurogallin formation by NAG was found 
to be diminishing after three minutes of the start of the reaction indicating a rapid 
turnover of the compound and unquenchable spontaneous auto-oxidation of 
pyrogallol (Fig. 4.2C). The acidic glucosides did not effect any noticeable 
change in pH on the buffer medium, at the levels tested.  
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FIGURE 4.2 Quenching of oxygen radicals by limonoid glucosides in vitro.  (A) 
Limonoid glycosides (5 mmol/L) were tested against 0.2 mmol/L pyrogallol in 0.5 
M Tris-HCl, pH 7.6.  The kinetics of decomposition was followed by absorbance 
readings at 325 nm. Vitamin C (5 mmol/L) and superoxide dismutase (40 U) 
were used as positive controls.  (B) Quenching of pyrogallol autooxidation by 
increasing concentrations of NAG (0.1-10 mmol/L). (C) Rate of pyrogallol 
oxidation based on the slopes for each compounds at 5 mmol/L level.  
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Cell viability. Human SH SY5Y neuroblastoma cells were treated with 
purified limonoid glucosides to test their cytotoxicity.  After the cells had reached 
confluence, the growth medium was supplemented with the limonoid glucosides 
to final concentrations of 5, 10 or 50 µmol/L and viability was measured at 12 h 
intervals.  Depending on concentration, significant cytotoxicity was apparent as 
early as 12 h of exposure and continued downward for 48 h (Fig. 4.3).  Cytotoxic 
potential was not uniform among the different limonoid glucosides, however.  LG 
and OG, for example, were clearly more effective in killing cells than an 
equivalent concentration of NAG or DNAG.  Indeed, the survival rate for the LG 
and OG showed no statistical difference when compared to cells that had been 
treated with similar concentrations of camptothecin.  Untreated cells showed 
greater than 60% survival after 36 h and about 50% at 48 h, whereas survival for 
cells treated with 50 µmol/L limonoid glucosides was less than 5% (Fig. 4.3).   
A second experiment using MTT reduction also tested cell viability.  By 
this analysis it was apparent that the cells survived a minimum of 36 h after 
exposure and that LG and OG had a stronger lethal potential than NAG or 
DNAG (Fig. 4.4).  In fact, DNAG was least effective in the downward curve of 
survival rate.  MTT reduction was undetectable after 36 h of exposure to LG, 
OG, or NAG.  Depending on limonoid glucosides concentration, cell death 
occurred more rapidly between 24 and 36 h after exposure.  Camptothecin, as 
expected showed the strongest lethal effects.   
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FIGURE 4.3 Toxicity of limonoid glucosides against SH-SY5Y cells in culture.  
Assays were based on trypan blue exclusion. Cells were exposed to 5, 10 or 50 
µM limonoid glucosides and tested for trypan blue-excluding cells at 12, 24, 36 
and 48 h after exposure.  Camptothecin was used as a positive control.  
Quantification was based on cell counts as performed in a hemocytometer and 
are expressed as 1000’s/mL.  Data shown represent triplicates readings for each 
treatment group and are expressed as the mean ± SE of the live cells.  
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FIGURE 4.4 Cell viability analysis based on MTT reduction, measured by the 
formation of formazon at 550 nm.  The values shown represent mean ± SE for 
n=3. Survival percentage was determined using control (untreated) cells as a 
norm. Camptothecin was used as a positive control.   
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A striking observation, however, was seen in cells that had been treated 
with LG and Ac-DVED-CHO in combination.  Cell death was suppressed for at 
least 48 h, even with the concentration of LG, the most lethal limonoid glucoside, 
as high as 50 µmol/L (Fig. 4.5).   Since Ac-DVED-CHO is a potent inhibitor of 
caspase activity, there was a clear indication that toxic action of limonoid 
glucosides could be exerted through the induction of apoptosis. 
Test of apoptosis.  It should be possible to observe apoptotic changes in 
the cells, if apoptosis induction is responsible for the decline in cell viability by 
limonoid glucosides.  Therefore, we tested for caspase 3/7 induction and DNA 
fragmentation.  In the caspase induction assay, the cells were treated with the 
limonoid glucosides for 12 h, harvested, washed with PBS and then lysed.  
Aliquots matched for their protein content were assayed for caspase 3/7 activity 
in the presence and absence of a caspase inhibitor.  Camptothecin was used as 
a positive control.  All of the limonoid glucosides at a set concentration (10 
µmol/L) induced caspase 3/7 activity (Fig. 4.6A).  Similar to the lethal potential 
on cell viability, there was a clear difference among the different limonoid 
glucosides.  Though the basal caspase activity changed very little over the 24 h 
experimental period, the caspase activity appeared to peak at 12 h and declined 
thereafter.  Although all limonoid glucosides were less effective than 
camptothecin, LG and OG were superior to NAG and DNAG in their caspase 
inducing efficacy.   
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FIGURE 4.5 Survivability of human neuroblastoma cells treated with LG alone or 
LG + Ac-DEVD-CHO, a known caspase inhibitor. Values are based on MTT 
reduction, are means ± SEM, n = 3.  
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 FIGURE 4.6 Induction of caspase 3/7 activity by limonoid glucosides. The cells 
were exposed to 10 µmol/L limonoid glucosides for 6, 12 or 24 h.   (A) Kinetics 
of caspase induction for each of the different limonoid glucosides.  Controls 
received no limonoids.  (B) The induction of caspase 3/7 activity at 12 h as a 
function of different concentration of limonoids.  Camptothecin (CAMP) was 
used as a positive control. Values are mean ± SD, n = 3. * Significantly different 
from control at P < 0.001. The activity is expressed as picomoles of 
rhodamine110 formed per µg of cell lysate protein per minute.  
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Figure 4.6B shows that caspase induction was a function of the 
concentration of limonoid glucosides in the medium.  As little as 1 µmol/L 
brought about a noticeable increment over basal (control) caspase activity; 5 
µmol/L brought about a significant difference (P < 0.05).  Importantly, those 
limonoid glucosides that were the most effective suppressors of cell growth, viz., 
OG and LG, were the strongest inducers of caspase 3/7 activity. The 12 h 
caspase activity had a strong correlation (r = -0.998, P = 0.002) to the cell 
survival. The data, therefore, confirmed the earlier study, which suggested that 
the cytotoxic effect of limonoid glucosides was manifested through apoptotic 
induction mechanism. 
Flow cytometry. As a further confirmation of apoptosis induction by the 
limonoid glucosides, a flow cytometry analysis was performed.  Cells were 
exposed to 10 µmol/L limonoid glucosides for 24 h, harvested, fixed in 70% 
ethanol, and treated with propidium iodide before the analysis.  Aggregates were 
removed by filtration through nylon.  Figure 4.7 shows that treated and control 
cells were mostly in the G0 and G2M phases with less numbers of cells in the S 
phase subpopulation.   The position marked A shows univariate DNA content, a 
marker of DNA degradation, was significantly higher for cells treated with LG, 
OG and camptothecin.  Background aggregates and debris (BAD) between G1 
and G2 phase, an indicator of apoptosis, was determined to be 35.4% for 
camptothecin, 31.3% for LG and 30.9% for OG, which was significantly higher (P 
< 0.05) compared to control (8.6%), NAG (17.5%) and DNAG (11.1%).  There 
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was no significant reduction in cell numbers at the G0/G1 phase between all 
treatment groups, but OG, LG and camptothecin significantly reduced the 
number of S phase cells, which essentially blocks the crucial proliferation phase. 
DNA content at S phase of the cell cycle indicated a reduction of 86.67% with 
LG, 82.36% with OG, 57.46% with NAG and 38.35% with DNAG, as compared 
to the known inhibitor like camptothecin. OG also significantly suppressed the 
G2/M phase.  Overall, the results provided evidence that limonoid glucosides act 
as antiproliferative agents through arresting critical growth stages of the cell 
cycle and inducing apoptosis. 
DNA fragmentation. The potential for limonoid glucosides to induce DNA 
breakage in sequel to apoptosis induction was determined through agarose gel 
electrophoresis.  In this assay DNA was extracted from control and treated cells, 
precipitated with ethanol, and chromatographed on 1% (w/v) agarose.  An equal 
amount of cellular DNA was applied to each lane of an electrophoresis gel.  
Figure 4.8 shows that untreated cells had high molecular weight DNA that was 
virtually intact as shown by the heavy staining of slow moving components, 
whereas cells treated with LG, OG, or camptothecin showed a spectrum of 
fragments that were present in a familiar ladder pattern typical of endonuclease 
cleaved DNA.  Fragmentation of DNA was less evident in cells treated with NAG 
and DNAG.  These data support the flow cytometry results and provide direct 
evidence for DNA degradation of neuroblastoma cells as a consequence of 
limonoid treatment. 
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 FIGURE 4.7 Flow cytometry analysis of DNA in SH SY5Y cells as a function of 
limonoid glucoside treatment.  Approximately 106 cells were treated with 10 µM 
limonoids for 24 h.  Measurements were taken with the excitation mode set at 
488 nm and the emission at 585 nm. The results were quantified with ModFit V3 
software.  
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FIGURE 4.8 DNA fragmentation analysis of SH-SY5Y cells after limonoid 
treatment.  Approximately 106 cells were treated with 10 or 50 µmol/L limonoid 
glucosides for 24 h.  An equal amount of DNA from each treatment group was 
applied to a 1% agarose gel. Lane marked MR shows 100 bp to 1000 bp 
molecular weight ladder. 
 
 
 
 
 
 
 
Cont       LG            OG            NAG         DNAG       CAMP      MR 
 
             10     50     10     50    10     50     10      50    10    50          
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 4.4 Discussion 
 Many epidemiological and controlled diet studies have reported that high 
intake of fruits and vegetables lower the risk of numerous degenerative diseases 
including cancer (110).  Although many bioactive compounds from citrus fruits 
were implicated, the potential of limonoid glucosides is believed to dwell in 
antioxidant and apoptosis inducing properties.      
 Two important facets of limonoid glucosides action, such as, an ability to 
quench O2- radicals and to induce apoptotic changes in neuroblastoma cells 
were studied here.  Quenching, as detected by an in vitro spectrophotometric 
assay, was evident only when relatively high (mmol/L) levels of the limonoid 
glucosides were present, which may limit chemopreventative significance.  
Furthermore, quenching appeared to occur only in the early stages of the 
reaction and, depending on concentration, did not endure beyond the first two or 
three minutes. The fact that quenching did not persist suggests the limonoid 
glucosides act stoichiometrically with O2- and, once modified, are unable to 
regenerate active forms.  Because of the high concentrations needed and the 
failure to recycle to active forms weakens the suggestion that limonoid 
glucosides are free radical scavengers in situ.   
 The limonoid glucosides tested in this study caused rapid death to 
undifferentiated neuroblastoma cells in culture.  Lethality occurred at micromolar 
concentrations, which suggests neuroblastoma cells are highly sensitive to their 
action.  Tian et al. (31) showed that the obacunone glucoside was superior to 
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nomilinic acid glucoside in causing the death of MCF-7 breast cancer cells in 
culture.  Moreover, the aglycones of NG and LG were as effective as the 
glucosides in killing cells, suggesting the glucoside appendage on the molecule 
is not important for toxic action.  The previous study with some limonoid 
glucosides, however, ruled out apoptosis as a cause because of the relatively 
high amounts (100 µg/L) needed to induce an apoptotic response (31).  In the 
present study, it has been demonstrated that limonoid glucosides as low as 1-5 
µmol/L (0.6-3.0 µg/L) induced caspase activity and fragmented DNA in SH-
SY5Y cells.   Why MCF-7 cells fail to show a similar heightened sensitivity 
against limonoid glucosides is not clear.  Apoptosis can be induced in SH-SY5Y 
cells by a number of external factors and conditions such as tumor necrosis 
factor- (111), amyloid--peptides (112), UV radiation (113) and ceramide (114).  
In contrast, retinoic acid, PGE-2, leptin, guanosine, interleukin (IL)-1 and IL-6 
appear to protect SH-SY5Y cells against oxidants and neurotoxins (115-118), as 
do flavones such as lutoelin, apigenin, and epigallocatechin (119-122).   The 
data suggest that limonoid glucosides are more apt to fit the category of toxic 
agents as opposed to protective agents, and unlike the flavones offer little or no 
protection against oxidants and neurotoxins in situ.  This hypothesis, however, is 
tempered by the observation that cancer cell lines HL-60, NCI-SNU-1, HeLa, 
SCOV-3, and HepG2 are unaffected by limonoid glucosides (31), which implies 
lethal action may be selective and dependent on cell type or differentiation state.          
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TABLE 4.1 
Summary of activity of limonoid glucosides on pyrogallol auto oxidation, caspase 
3/7  induction and cell viability. Values expressed are mean ± SE.  DNA content 
is expressed as percent of untreated. 
 
 LG OG NAG DNAG 
Inhibition of superoxide 
radical (mmol/L) a 
7.88±0.8 4.62±0.13 3.11±0.09 3.53  ± 0.12 
Induction of caspase 3/7 
(µmol/L) b 
8.36±1.15 8.17±0.88 14.89±0.51 18.40 ± 0.57 
Cell death at 24 h, trypan 
blue exclusion (µmol/L) c 
5.14±0.88 4.197±0.66 28.59±2.02 29.53 ± 0.57 
Cell death at 24 h, MTT 
reduction (µmol/L) d 
6.05±0.73 5.54±0.77 22.43±1.57 25.53 ± 1.45 
Percent reduction in DNA 
of S phase (% CV) e 
86.67(4.7) 82.36(3.7) 57.46(4.7) 38.35(4.4) 
 
a
 IC50 values calculated according to Stahle et al. (101) using a linear 
regression equation. 
b
 Induction of 50% of caspase activity as compared to 10 µmol/L 
camptothecin used as positive control. 
c Cell survival (50%) after 24 h of treatment. Measured using 
hemocytometer and compared with that of control. 
d Cell survival based on MTT reduction by live cells measures at 550 nm 
and compared with that of control. 
e Reduction in DNA content at S-phase was measured using flow 
cytometer with propidium iodide staining and compared with that of control. 
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It is important to note the difference in the efficacy by different limonoid 
glucosides.  It is clear that LG and OG induced cell death at one-fourth the 
concentrations of NAG and DNAG (Table 4.1).  Caspase induction and DNA 
fragmentation was also achieved at lower concentrations of LG and OG than 
NAG and DNAG.  Quenching, however, favored NAG.  A careful inspection of 
the structures (Fig. 4.1) shows that NG and LG share the same structural 
features as NAG and DNAG with the exception of a sealed A ring in the OG and 
LG molecules.  Miller et al. (23) earlier had speculated that the A ring as 
opposed to the D, is more decisive in its biological activity of limonoid 
glucosides.  Our data strongly support that by showing greater apoptosis-
inducing potential, that may also be associated with the A ring of the molecule.      
Future research endeavors can now turn to the mechanism of apoptosis 
induction to explain the underlying mechanism of the limonoid glucosides on SH-
SY5Y cells.  Calcium, acting through the activation of two Ca2+-dependent 
proteases, mu-calpain, and caspase 12, has been strongly implicated in 
induction of apoptosis and the regulation of the apoptotic signaling pathway 
(123).   Mitochondria regulate apoptosis in vertebrates by releasing cytochrome 
c, an inducer of caspase 3, and Bcl-2 regulates this release (124).  Activation of 
the JNK signaling pathway, an early event in the induction of apoptosis in 
neuronal cells (111), leads to the phosphorylation of c-Jun and Bcl-2, two factors 
that control apoptosis. What effect limonoid glucosides may have on these 
internal events is ripe for further investigation.  One more consideration is the 
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synergistic action by which one limonoid promotes the action of another.  
Mertens-Talcott (125), showed that ellagic acid significantly potentiated the 
action of quercetin in stimulating caspase activity in cultured MOLT-4 human 
leukemia cells.  A combination of the two fruit polyphenols gave robust 
anticarcinogenic effects than either one alone.  This observation suggests 
limonoid glucosides could act in concert with flavones to promote an action.  In 
nutrition synergistic health promoting effects achieved by whole fruit 
consumption, rather than individual molecules.  
 In conclusion, the data in this study strongly support limonoid glucosides 
at micromolar concentrations as being toxic to cultured neuroblastoma. Because 
limonoid glucosides are not lethal to all cancer cells (31), they may target 
specific cells types. Consequently, it is vital to recognize the vulnerable site(s) in 
cells that underlie their mechanisms of action.       
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CHAPTER V 
 
 
EFFECT OF LIMONOIDS ON COLONIC ADENOCARCINOMA (Caco-2), 
 
NEUROBLASTOMA AND NON-CANCEROUS OVARY (CHO) CELLS 
 
 
5.1 Synopsis 
Purified limonin, limonin glucoside, obacunone, obacunone glucoside, 
nomilin, and deacetylnomilin along with mixtures of limonoid aglycones and 
glucosides were tested for toxic effects on human SH-SY5Y neuroblastoma and 
colon carcinoma (Caco-2) cell lines and were compared with the mammalian 
non-cancerous Chinese hamster ovary (CHO) cells. Limonoid glucosides have 
been shown to have greater cytotoxic effects than aglycones and that the effects 
were specific to cancerous cells. The effects were significant (P < 0.001) over 24 
to 36 h when compared with the untreated cells. Flow cytometric analyses of 
limonoid treated neuroblastoma cells showed a marked increase in DNA content 
of aneuploidic cells within 24 h, which are considered to be a prognostic factor in 
neuroblastoma. The percentage of aneuploidic cells following treatment were 
36% for LG, 26% for limonin and more than 42% for limonoid glucoside 
mixtures. The results confirm that both limonoid aglycones and glycosides are 
lethal to cancer cell lines; however, glycosides are the most active apoptotic 
inducing form, even though both forms arrest cell growth. 
 
 
 69  
5.2 Introduction 
Secondary metabolites have often been proven to be beneficial to human 
health. More than 120 important prescription drugs in the U.S. are derived from 
secondary plant metabolites which comprise about 25% of the total drugs in use 
(126). With innumerable chemopreventive properties, these phytochemicals 
have been divided into either cancer-blocking agents or cancer-suppressing 
agents (92). The blocking agents work through scavenging the carcinogens by 
CYP/GST mediated metabolism and detoxification, quenching ROS, and 
blocking the cellular targets. The suppressing agents restrain the proliferation 
and progression of the cancer by activating several transcription factors), 
inducing apoptosis, arresting the cell cycle (3-19, 92). 
Statistics from American Cancer Society show an estimated 1,372,910 
new cases and a total of 570,280 deaths by cancer in U.S. in 2005 (33).   Of 
these, about 145,000 new cases and about 56,000 deaths will occur due to 
colorectal cancer. Neuroblastomas account for about 10% childhood cancer with 
an annual incidence of 6-8 per million (50,127). Furthermore, the overall costs of 
cancer for the year of 2005 is estimated to be $189.8 billion with $69.4 billion in 
direct medical expenditures and $103.5 billion in indirect mortality costs, which 
include the costs of lost productivity due to premature death (33). An estimate by 
the National Cancer Institute indicates that one in four cancer deaths are diet 
related and that eight of ten cancer cases have a nutrition/diet component (33).  
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National Cancer Institute designer programs identified citrus fruits as 
especially nutrient rich foods containing more than a dozen classes of beneficial 
phytochemicals (4,5). Chemopreventive properties of citrus limonoids have been 
discussed in detail in the previous chapters. Epidemiological, cell culture and 
animal studies have shown that citrus limonoids can prevent several types of 
cancers (15-31). Though the antiproliferative effects of citrus limonoids are found 
to be mediated through inhibition of cytochrome P450, antioxidant activity and 
apoptotic induction in earlier experiments, their effects on normal cells and other 
cancer cell lines have yet to be ascertained.  Strategies to offset the 
malignancies of colorectal cancer and neuroblastomas are vital. This study 
report the cytotoxic and apoptotic effects of the purified limonoids on human SH-
SY5Y neuroblastoma (CRL-2266), colonic adenocarcinoma (Caco-2) and 
assessed the effects with a non-cancerous Chinese hamster ovary cells (CHO).  
 
5.3 Materials and methods 
Cell cultures. Human SH-SY5Y neuroblastoma cells (CRL-2266), colonic 
adenocarcinoma cells (Caco-2), and Chinese hamster ovary cells (CHO) were 
purchased from the American Type Culture Collection (Bethesda, MD). SH-
SY5Y cells were cultured in 10% (v/v) fetal bovine serum in a 1:1 mixture of 
Eagle’s minimum essential medium with non-essential amino acids, 0.001% 
antimycotic-antibiotic and Ham’s F12 medium as previously described (108). 
HepG2 and  Caco-2 cells  were grown in 10% (v/v) and 20% (v/v)  fetal bovine 
 71  
serum in  Eagle’s minimum essential medium with 2 mmol/L  L-glutamine and 
Earle’s balanced salt solutions (BSS) adjusted to contain 17.85 mmol/L sodium 
bicarbonate, 0.1 mmol/L non-essential amino acids, and 1 mmol/L sodium 
pyruvate. CHO cells were cultured in 10% (v/v) fetal bovine serum Ham’s F12K 
medium with 2 mmol/L L- glutamine adjusted to contain 17.85 mmol/L sodium 
bicarbonate. Cells were grown on 25 cm3 Falcon culture flasks at 37oC under 
5% CO2.  When the cells reached 70-80% confluence they were detached from 
the flasks using either Pucks EDTA (SH-SY5Y, CHO) or trypsin EDTA (CacO-2) 
and quantified in a hemocytometer.  Approximately 104 cells/mL (1000/well) 
were sub-cultured into 96-well culture plates and incubated for 24 h (SH-SY5Y, 
CHO) and 48 h (Caco-2), to attain 70% confluence before the treatments. Fresh 
medium was added to each well at the beginning of the treatments. Stock 
solutions of aglycones were prepared in DMSO and glucosides in water.   
Cell viability. The cells in triplicate were incubated in culture medium 
supplemented with limonoid glucosides (5-50 µmol/L final concentration) and 
cell viability was monitored at 12 h intervals over the next 48 h. Care was taken 
to keep the DMSO levels below 0.5% which had no apparent effect on cell 
growth. Viability determinations were based on the reduction of MTT reagent 
(3[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium) by active mitochondria as 
described (109).  The morphological differences between limonoid treated and 
untreated cancer cell lines were ascertained using a confocal microscopy using 
a green fluorescent filter. 
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Flow cytometry analysis. Cells were treated with limonoids for 36 h and 
harvested as before. Between 106 to 107 cells in PBS were centrifuged (200 x g, 
6 min, 25oC), washed 3 times with PBS and the cell pellet was resuspended in 
500 µL of PBS to which added 0.1% (v/v) Triton X-100 in PBS, 200 µg/mL of 
DNase-free RNase A and 50 µL/mL of propidium iodide in 4 mmol/L sodium 
citrate buffer.  After a 15 min incubation at 37oC to destroy RNA, the suspension 
was filtered through nylon and collected in separate tubes that fit a FACS 
Caliber flow cytometer (Beckton Dickenson, San Jose, CA USA), equipped with 
a 15 mW argon ion laser. DNA fluorescence readings were taken with an 
excitation of 488 nm and emission with a 585 nm filter, with a doublet 
discrimination module to differentiate G2 cells from cell doublets using pulse 
width area.  The existence of DNA aneuploidy was described as the existence of 
two Go/G1 peaks in the DNA histogram as described by Abad et al. (128). 
Statistical analysis. Experimental results for cell viability represent 
triplicate for each treatment group and are expressed as means ± standard error 
(percent).  A one-way ANOVA was used with a P-value of less than 0.001 with 
Fisher’s least significant difference test for inter group comparisons.  Analyses 
were done with SPSS statistical analysis software (Version 11.0). Distribution 
analysis of Go/M, S and G2/M phases of the cell cycle were performed on 
propidium iodide stained gated cells for the exclusion of doublets using 
ModFitLT software (Version 3.1, PMac, Beckton Dickenson).  
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5.4 Results 
Effect of limonoids on the viability of SH-SY5Y, Caco-2 and CHO cells. 
In accordance with the previous report on the effect of limonoid glucosides on 
the induction of apoptosis in human SH-SY5Y neuroblastoma cell lines (127), a 
slow but similar effect for the limonoid aglycones was observed. The 
morphological differences observed using confocal microscopy clearly indicated 
a rapid response for the limonin 17-D glucopyranoside (LG) as opposed to that 
of limonin and obacunone aglycones (Fig. 5.1). The effects were consistent with 
both time and dose dependent assays (Table 5.1). While limonoid mixtures had 
definitive effects on the viability of both Caco-2 and SH-SY5Y cell lines, the 
response of both pure as well as mixtures was selective towards cancerous cell 
lines (Fig. 5.2). Neuroblastoma cell lines were found to be more sensitive than 
the colon carcinoma cells for nomilin (Fig. 5.2). Although all of the pure 
compounds seemed to have similar levels of cytotoxicity on SH-SY5Y cells the 
relative effects appeared to be strong for obacunone followed by limonin, 
nomilin, and deacetylnomilin (Table 5.1). There were no significant differences 
(P < 0.001) between limonin and obacunone. Limonin, nomilin, and obacunone 
had same cytotoxicity towards Caco-2 and SH-SY5Y cell lines at 48 h.  
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FIGURE 5.1 Time-dependent changes in percent viable cells following treatment 
with pure aglycones or limonoid mixtures. Limonoid concentration, 25 mmol/L. 
Values are mean ± SEM, n = 3, based on untreated controls.   
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TABLE 5.1 
Percent viability of SH-SY5Y neuroblastoma cells treated with purified limonoid 
aglycones. Values are mean ± SEM (%), n = 3. 
 
 
 
 
There was a significant difference (P < 0.001) between glucoside and 
aglycone mixtures with the former being more effective within 24 h of treatment 
(Table 5.2). The results clearly indicated the minimal effect on the Chinese 
Time 
(h) 
Conc. 
(µmol/L) 
Limonin Nomilin Obacunone Deacetylnomilin 
12 5 96.85±2.46 98.17±3.98 98.23±4.41 100.0±3.88 
 10 93.27±3.54 95.56±4.25 96.53±5.62 97.32±2.15 
 25 91.18±4.87 88.32±1.13 88.91±4.36 91.13±4.11 
 50 87.12±6.13 81.17±2.34 84.24±6..67 85.34±4.23 
24 5 83.37±4.60 87.89±2.60 85.62±5.32 88.74±1.81 
 10 87.20±3.73 83.59±2.41 84.25±1.72 90.89±1.71 
 25 82.45±5.23 72.94±3.00 74.96±1.93 77.97±4.10 
 50 65.98±5.07 59.87±1.36 57.18±3.12 67.75±1.44 
36 5 79.85±4.65 84.99±4.46 80.96±3.33 85.93±3.78 
 10 74.54±6.35 71.03±.3.71 67.27±2.43 76.25±4.67 
 25 69.67±3.34 60.20±2.76 62.68±3.65 61.37±2.76 
 50 55.95±3.12 58.19±2.65 53.36±1.65 61.99±3.56 
48 5 68.13±2.35 74.35±1.24 71.25±4.09 75.34±3.21 
 10 62.65±2.27 65.46±4.65 58.54±3.87 65.43±2.13 
 25 58.42±5.54 62.46±5.23 49.41±3.91 51.25±2.11 
 50 45.87±5.34 48.54±3.67 41.32±2.88 50.28±2.28 
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hamster ovary cells (Fig. 5.3) and thus confirm non-toxicity on normal cells. Inter 
group comparisons showed no significant differences (P = 0.227) between the 
aglycone and glucoside mixture from oranges at 25 ppm after 24 h.  
 
TABLE 5.2 
Percent viability of SH-SY5Y neuroblastoma cells treated with mixtures of 
limonoid aglycones and glucosides from orange and grapefruits. Values are 
mean ± SEM (%), n = 3. 
 
 
Time 
(hr) 
Conc. 
(ppm) 
Grapefruit 
aglycone 
mixture 
Orange 
aglycone 
mixture 
Orange 
glucoside 
mixture 
Grapefruit 
glucoside 
mixture 
12 5 91.12±4.23 94.21±1.94 95.78±4.61 96.32±2.31 
 10 89.57±3.56 87.16±2.05 89.07±3.21 91.18±4.12 
 25 88.12±2.11 81.65±2.76 82.34±2.34 89.43±3.33 
 50 82.55±3.57 80.23±3.29 81.16±1.65 83.54±2.34 
24 5 85.69±2.69 88.91±2.46 84.60±6.93 94.61±4.69 
 10 90.61±2.80 90.31±3.55 83.82±1.43 79.57±2.06 
 25 76.81±3.35 73.95±5.51 64.29±3.04 60.53±0.94 
 50 58.91±1.86 58.49±1.05 46.80±3.57 38.30±1.96 
36 5 25.10±2.56 24.48±1.07 21.61±1.34 25.26±1.86 
 10 18.26±1.43 25.64±1.78 24.16±1.17 26.33±1.13 
 25 19.39±1.05 18.30±1.63 13.31±2.09 12.84±2.34 
 50 14.26±1.96 12.98±1.13 6.80±1.76 6.59±1.46 
48 5 17.15±1.46 19.12±1.32 11.24±1.06 13.15±1.07 
 10 11.10±1.78 11.16±0.65 6.31±1.98 4.18±.97 
 25 7.32±1.71 0.32±0.13 0.00±0.00 0.00±0.00 
 50 2.31±0.95 0.00±0.00 0.00±0.00 0.00±0.00 
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FIGURE 5.2 Confocal images of SH-SY5Y neuroblastoma cells treated with 
limonoid glucosides and aglycones, from Figure 5.1. Panels A and B untreated 
cells at 0 and 48 h. C and D, 25 µmol/L LG for 24 and 48 h; E and F, 25 µmol/L 
obacunone.  
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FIGURE 5.3 Confocal images of Caco-2 and non-cancerous Chinese hamster 
ovary (CHO) cells treated with limonoids, from Figure 5.1. Panels A,B, Caco-2 
cells treated with 25 µmol/L of limonoid glycoside mixture for 24 and 48 h, 
respectively. Panels C and D, Chinese hamster ovary cells treated with the 
limonoid glycoside mixture. 
 
Limonoids induce aneuploidy. Limonoid treatment of neuroblastomas 
increased the percentage of aneuploidic cells to 2- to 3-fold over the untreated 
controls (Fig 5.4 & Table 5.3). The substantial increase of aneuploidy in the 
cells treated with limonoid mixtures. The mixtures consisted of 31% LG, 34% 
OG, 11% NAG, 8% DNAG, 7% nomilin glucoside, 4% DNG with several 
unknown compounds. The significant reduction in G2/M phase of the cell cycle 
can be ascribed to the inhibition of mitosis due to differing chromosome number, 
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which can lead to the non-division of aneuploidic cells, eventually leading to 
death of the cells. Thus, it can be discerned from the flow DNA frequency 
histogram data (Table 5.3) that both glycosides as well as aglycones inhibit cell 
proliferation. 
  
 
FIGURE 5.4 Flow cytometric DNA content analysis for cell cycle of SH-SY5Y 
neuroblastoma cells stained with propidium iodide after 36 h exposure. Panel A, 
untreated cells; panels B, C, and D, 25 µmol/L limonin glucoside, limonoid 
glucoside mixture and limonin, respectively. 
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TABLE 5.3 
Percent DNA content of the SH-SY5Yneuroblastoma cells in the various phases 
of the cell cycle, treated with limonoids at 25 µmol/L for 36 h. The values were 
obtained based on the DNA frequency histogram (ModFitLT software V3.1). 
 
 
5.5 Discussion 
Previous studies have shown that apoptosis is the primary cause of 
neuroblastoma cell death by limonoid glycosides. In this study the cytotoxicity of 
limonoids was assessed in human SH-SY5Y neuroblastoma and colonic 
adenocarcinoma (Caco-2) cells and compared with two non-cancerous Chinese 
hamster ovary (CHO) cell lines. It was evident that neuroblastoma cells were 
more sensitive to limonoids than were colon carcinoma cells. Limonoid 
 
Diploid 
Total (%)  %G1 CV 
Aneuploid 
Total (%)  %G1 %G2/M 
Untreated 88.2 87.3 10.1 11.9 77.5 22.5 
Limonin 73.3 81.5 6.1 26.8 83.0 17.0 
Obacunone 63 77.6 8.1 37.0 85.7 14.4 
Nomilin 56.1 78.1 8 44.0 88.9 11.1 
LG 64 77.6 9 36.0 86.2 13.8 
OG 61.2 79 8 38.8 88.7 11.3 
NAG 72.4 83.4 5.3 27.6 84.7 15.3 
Glu Mix(O) 52.3 73.2 5.9 47.7 93.3 6.7 
Glu Mix (G) 57.1 80.7 7.9 42.9 92.1 7.9 
Agl Mix (O) 58.4 77.2 5.1 41.6 91.6 8.4 
Agl Mix (G) 60.3 81.6 5.1 41.6 89.2 10.8 
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cytotoxicity varied depending on the type of cancer cell and the type of limonoid 
applied. While both limonoid aglycones and glucosides at micromolar levels 
appeared to arrest cell growth, biochemical and morphological data showed that 
the glycosides were clearly more effective in inducing rapid cell death. Neither 
pure compounds nor mixtures showed toxicity against the viable mammalian 
CHO epithelial cells. 
Corresponding to our previous report showing the apoptotic inducing 
ability of LG and OG, here the cell death on both SY5Y as well as Caco-2 cells 
by limonin and obacunone was observed, but at a significantly slower pace and 
never to the same extent. This confirms the killing potential of limonoid 
aglycones as reported by Miller et al. (22, 23). Considering the solubility factor 
that could hinder the killing potential, the aglycones were supplemented through 
non-toxic concentrations of DMSO, giving both compounds equal access to the 
cell’s interior and sensitive site(s). Obacunone and other purified aglycones were 
as effective as glycosides in stopping cell division, but considerably inferior in 
rapid killing. The data, therefore, imply that stopping cell division and inducing 
cell death by apoptosis may be two separate and independent actions of 
limonoids on cancer cells. Aglycones are capable of arresting the cell 
proliferation, but weak in inducing the apoptosis. The propensity of aglycone and 
glycosidic mixtures speaks strongly for synergistic events beyond absorption, 
and from a nutritional perspective, whole fruit or whole juice consumption to 
maximize beneficial effects. 
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Chromosomal aberrations in cell DNA content (aneuploidy) measured by 
flow cytometry provide objective information and major prognostic factors for 
neuroblastomas (127). Aneuploidy is common in neuroblastoma cells and has 
been used to predict tumor aggressiveness and successful response to 
chemotherapy. In neuroblastoma tumor cells absence of aneuploidy (near 
diploid or near tetraploid DNA content) is confirmed to be the more aggressive 
pattern of neuroblastoma (127-130). Look et al. (130) reported that tumors with 
greater numbers of aneuploidic cells responded well to chemotherapy. 
Limonoids increased the number of aneuploidic SH-SY5Y cells. A previous 
report correlated cell cycle arrest with an increase in G1 phase cells, thus 
inferring a block  in the transition to the S phase of the cell cycle. Enhancing 
aneuploidy raises the possibility that cell cycle arrest could also be occurring at a 
later stage of cell division, particularly the separation into two daughter cells 
which is shown as an arrest at the G2/M phase.  
In conclusion, with proven anticancer properties, limonoids can now be 
considered as lead structures for anticancer drugs. Viability studies indicate that 
molecules patterned after limonoid glycosides may have greater commercial 
potential. As cellular permeability, water solubility, and metabolic change all play 
pivotal roles in the overall efficacy of a natural compound’s performance (131), 
the glycosides appear to excel over aglycones. These studies advocate citrus 
fruit as a valuable functional food which may thwart cancer in human and could 
augment demand for citrus and citrus products. 
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CHAPTER VI 
 
 
CONCLUSIONS 
 
 
Combination of ion-exchange and crystallization techniques presented in 
this dissertation provides an efficient and economical method for the large scale 
purification of limonoids and flavonoids from citrus byproducts. The methods 
developed were found to be highly specific and with more than 80-fold increase 
in total yields, than present methods in practice for the isolation of limonoid 
glucosides. The removal of large amounts of naringin in particular, increased the 
purification efficiency. One kilogram of dried orange and grapefruit seeds yielded 
8.62 and 9.31 g of limonin, 0.62 and 0.47 g nomilin, 0.9 and 0.63 g of 
deacetylnomilin and 0.21 and 0.17 g of obacunone respectively. An average of 
16 g of dried limonoid glucosides and 9.8 g flavonoid mixtures were obtained 
from 1 Kg of clarified citrus molasses concentrate. Preparative HPLC separation 
of these semi-purified mixtures resulted in high yields of limonoid glucosides with 
more than 90% purity. Considering the abundance of aglycones in seeds, and 
glucosides in molasses, citrus byproducts provide an excellent source for bulk 
purification. 
In our first biological activity study using the purified compounds, limonoids 
and flavonoids have shown to effect redox-cycling enzymes in a dose dependent 
and dose independent manner. Limonoids selectively and quantitatively inhibited 
the dealkylase and hydroxylase reactions performed by cytochrome P450 
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isoforms. All the limonoids significantly (P < 0.001) inhibited EROD and MROD 
activity of CYP1B1 and CYP1A2. Limonoid glucosides were found to be better 
inhibitors than aglycones. The acidic limonoid glucoside, NAG, had the highest 
inhibitory effect on most of the isoforms tested. Correspondingly, the flavonoids 
tested also significantly (P < 0.001) inhibited EROD and MROD activity of 
CYP1B1 and CYP1A2. Hydroxylation activity of human CYP aromatase, CYP19, 
was inhibited reversibly by LG and non-competitively by NAG. The limonoid 
glucosides and aglycones were also found to inhibit CYP 3A4 hydroxylation. 
NAG and nomilin were the best inhibitors of CYP3A4, drug metabolizing CYP 
isoenzyme. The IC50 for limonoids varied considerably, depending upon the 
type of isoforms. The limonoid glucosides were found to be the better inhibitors 
when compared to the aglycones. The effects of citrus bioactive compounds on 
the partial inhibition of CYP enzymes represent a unique mechanism in the 
anticarcinogenesis strategy. One of the mechanisms is through the reduction in 
the generation of reactive oxygen species. This study also supports the role of 
citrus bioactive compounds on the increased bioavailability of orally 
administered drugs. Partial inhibition of CYP3A4 may represent an alternate 
strategy for the reduction in medical costs, but needs further studies on the 
mechanistic and dose response relations. Structural variations in different 
limonoid and flavonoid molecules can be ascribed to the differences in efficacy 
in inhibiting different CYP isoenzymes. 
 85  
A complimentary means by which to address the question “Does limonoids 
acts as antioxidants?” relies on their ability to quench the reactive oxygen 
species.  In vitro studies with four pure limonoid glucosides have shown effective 
superoxide scavenging and perceptible differences in the quenching efficacies, 
at 5 mmol/L.  NAG emulated a quenching effect to an equivalent concentration 
of vitamin C, and was superior to LG, OG, and DNAG.  
The study conducted to evaluate the cytotoxic effects of limonoid 
glucosides confirmed that micromolar amounts of LG and OG induce rapid 
necrosis of SH-SY5Y cells in culture.  Viability studies showed significant (P < 
0.001) reduction in survivability by LG and OG within 24 h of treatment. The 12 h 
caspase 3/7 activity had a strong negative correlation (r = -0.998, P = 0.002) to 
the cell survival. The data confirmed that the cytotoxic effect of limonoid 
glucosides was manifested through apoptotic induction mechanism which was 
further endorsed through DNA fragmentation profile. Univariate DNA content 
was significantly higher for cells treated with LG, OG.  Background aggregates 
and debris (BAD) between G1 and G2 phase, an indicator of apoptosis, was 
significantly higher (P < 0.05) for LG and OG compared to control. Similarly DNA 
content at S phase of the cell cycle indicated a significant reduction by LG and 
OG as compared to NAG, DNAG (86.67% with LG, 82.36% with OG, 57.46% 
with NAG, and 38.35% with DNAG). Overall, these results confirm the 
antiproliferative property of limonoid glucosides are manifested through arresting 
critical growth stages of the cell cycle and inducing apoptosis.  
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The last study conducted to elucidate the cytotoxic effects of citrus limonoid 
aglycones and glucosides on human cancer cell lines such as SH-SY5Y 
neuroblastoma and colon carcinoma (Caco-2) cell lines showed a specific 
cytotoxic effects on cancerous cells and spared the non cancerous Chinese 
hamster ovary (CHO) cells. Limonoid glucosides have shown greater cytotoxic 
effects than aglycones and the effects were significant (P < 0.001) over the 
period of 24 to 36 h when compared with the untreated cells. The morphological 
differences observed on the confocal microscopy clearly designate a rapid 
response for the LG as against limonin and obacunone aglycones. The effects 
were consistent with both time and dose dependent assay. Neuroblastoma cell 
lines were found to be more sensitive than the colon carcinoma cells incase of 
mixtures and nomilin during the initial period of exposure. The flow cytometric 
analysis of limonoid treated neuroblastoma cells showed a marked increase in 
DNA content of aneuploidic cells within 24 h. Percent aneuploidic cells were 
found to be 36% for LG, 26% for limonin and more than 42% for limonoid 
glucoside mixtures indicating a synergistic effect of different limonoid glucosides. 
The significant reduction in G2/M phase of the cell cycle confirms the results in 
chapter IV that limonoids inhibit S phase of the cell cycle. The inhibition of 
mitosis due to differing chromosome number in the aneuploidic cells, can lead to 
the non division of cells, eventually leading to death. These results confirm that 
both limonoid aglycones and glycosides are lethal to cancer cell lines; however 
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glycosides are the most active apoptotic inducing form, even though both forms 
arrest cell cycle. 
In summary, with wide biological applications, anticancer properties and 
possible role in cell signaling mechanisms, limonoids can now be considered as 
a possible lead structure for a new class of anticancer drugs. The bulk 
purification methods could aid further research in the area of clinical trials, food 
additives, and nutritional supplements. As cellular permeability, water solubility, 
and metabolic change all play pivotal roles in the overall efficacy of a natural 
compound’s performance, the glycosides appear to excel over aglycones. With 
citrus being a store house for many nutritionally important bioactive compounds, 
our studies strongly advocate citrus as a valuable functional food, particularly for 
the prevention of cancer in children.  
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